This is a table of named entities, their types, and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel. Please keep in mind that named-entity extraction is not as accurate as more generic parts-of-speech extraction. Unusual results will appear here.
entity | type | frequency |
---|---|---|
covid | ORG | 1061 |
sars | DISEASE | 503 |
covid 19 | ORG | 466 |
infection | DISEASE | 407 |
sars cov 2 | ORG | 341 |
virus | TAXON | 335 |
coronavirus | TAXON | 286 |
cov | CHEMICAL | 264 |
viral | TAXON | 222 |
china | GPE | 221 |
copd | ORG | 220 |
individuals | TAXON | 180 |
human | TAXON | 172 |
pd | ORG | 166 |
tbi | ORG | 165 |
coronavirus | TAXON | 165 |
death | DISEASE | 159 |
wuhan | GPE | 153 |
pneumonia | DISEASE | 142 |
rpl | ORG | 116 |
inflammation | DISEASE | 114 |
obesity | DISEASE | 112 |
sars cov | ORG | 96 |
ci | ORG | 88 |
hypertension | DISEASE | 86 |
asthma | DISEASE | 86 |
igg | ORG | 81 |
coronavirus disease | DISEASE | 80 |
rbd | ORG | 79 |
diabetes | DISEASE | 73 |
fmt | ORG | 73 |
cvd | ORG | 72 |
coronavirus disease | DISEASE | 72 |
ncov | ORG | 72 |
bias | CHEMICAL | 67 |
infections | DISEASE | 66 |
oxygen | CHEMICAL | 65 |
msc | ORG | 65 |
iga | ORG | 65 |
viruses | TAXON | 61 |
anxiety | DISEASE | 61 |
burnout | DISEASE | 60 |
parkinson s disease | DISEASE | 59 |
deaths | DISEASE | 58 |
ht | ORG | 58 |
clin med doi | PERSON | 57 |
aldosterone | CHEMICAL | 55 |
angiotensin | CHEMICAL | 54 |
mice | TAXON | 50 |
tnf | ORG | 50 |
cdi | ORG | 50 |
aceis | CHEMICAL | 48 |
japan | GPE | 46 |
traumatic | DISEASE | 46 |
stroke | DISEASE | 45 |
humans | TAXON | 45 |
viral infection | DISEASE | 44 |
rna | ORG | 44 |
stim | ORG | 42 |
pims | ORG | 42 |
il | ORG | 42 |
germany | GPE | 42 |
pneumonia | DISEASE | 41 |
italy | GPE | 41 |
sci | ORG | 40 |
sestamibi | CHEMICAL | 39 |
mers | DISEASE | 39 |
smoking | CHEMICAL | 38 |
orthodontic | DISEASE | 38 |
us | GPE | 38 |
injuries | DISEASE | 37 |
asthma exacerbations | DISEASE | 37 |
gcs | ORG | 37 |
depression | DISEASE | 35 |
cxr | ORG | 35 |
lopinavir ritonavir | CHEMICAL | 35 |
cancer | DISEASE | 34 |
human | TAXON | 34 |
angiotensin | CHEMICAL | 33 |
weight loss | DISEASE | 32 |
sepsis | DISEASE | 32 |
php | ORG | 32 |
limc | ORG | 32 |
cc | CHEMICAL | 32 |
critically ill | DISEASE | 31 |
mouse | TAXON | 31 |
pain | DISEASE | 31 |
virus | TAXON | 30 |
covs | TAXON | 30 |
angiotensin ii | CHEMICAL | 29 |
spain | GPE | 28 |
iqr | PERSON | 28 |
ali | ORG | 28 |
sic | ORG | 27 |
adr | ORG | 27 |
acei | ORG | 27 |
bacterial | TAXON | 27 |
hydroxychloroquine | CHEMICAL | 27 |
fibrosis | DISEASE | 26 |
coagulopathy | DISEASE | 26 |
animal | TAXON | 26 |
uk | GPE | 26 |
dm | ORG | 26 |
dic | ORG | 26 |
ards | DISEASE | 26 |
ons | ORG | 25 |
6mwt | ORG | 25 |
himc | CHEMICAL | 25 |
igm | ORG | 25 |
viral rna | TAXON | 25 |
raas | ORG | 25 |
cholangitis | DISEASE | 25 |
fever | DISEASE | 25 |
viral infections | DISEASE | 25 |
sestamibi | CHEMICAL | 24 |
choledocholithiasis | GPE | 23 |
airway inflammation | DISEASE | 23 |
obesity | DISEASE | 23 |
ecg | ORG | 23 |
resveratrol | CHEMICAL | 22 |
psychiatric | DISEASE | 22 |
contagion | DISEASE | 22 |
kd | ORG | 22 |
infection | DISEASE | 21 |
arbs | CHEMICAL | 21 |
emg | ORG | 21 |
israel | GPE | 21 |
k | CHEMICAL | 21 |
cardiovascular disease | DISEASE | 21 |
heart failure | DISEASE | 21 |
respiratory distress syndrome | DISEASE | 20 |
who | ORG | 20 |
clostridium difficile | TAXON | 20 |
atp | ORG | 20 |
arb | ORG | 20 |
md | GPE | 19 |
ee | CHEMICAL | 19 |
europe | LOC | 19 |
hf | ORG | 19 |
hypertension | DISEASE | 19 |
acute respiratory syndrome coronavirus 2 sars cov | DISEASE | 19 |
middle east | LOC | 19 |
glucose | CHEMICAL | 19 |
outbreaks | TAXON | 19 |
overweight | DISEASE | 19 |
ischemia | DISEASE | 19 |
ptsd | ORG | 18 |
clostridium | GPE | 18 |
hypertensive | DISEASE | 18 |
rpcp pd | ORG | 18 |
parkinson s disease | DISEASE | 18 |
infectious disease | DISEASE | 18 |
azithromycin | CHEMICAL | 18 |
creatinine | CHEMICAL | 18 |
diabetes mellitus | DISEASE | 18 |
the creative commons attribution cc | ORG | 17 |
myocardial infarction | DISEASE | 17 |
hypoxia | DISEASE | 17 |
cord injury | DISEASE | 17 |
animals | TAXON | 17 |
traumatic | DISEASE | 17 |
mers cov | ORG | 17 |
los | ORG | 17 |
hrv | ORG | 17 |
diabetes | DISEASE | 17 |
cad | ORG | 16 |
cbt | ORG | 16 |
viral | TAXON | 16 |
ami | ORG | 16 |
rt pcr | ORG | 16 |
tca | CHEMICAL | 16 |
ischemic stroke | DISEASE | 16 |
lung injury | DISEASE | 16 |
parathyroid carcinoma | DISEASE | 16 |
cardiac injury | DISEASE | 16 |
tocilizumab | CHEMICAL | 16 |
fda | ORG | 15 |
mds | DISEASE | 15 |
arf | ORG | 15 |
bnp | ORG | 15 |
hiv | TAXON | 15 |
ige | ORG | 15 |
n | GPE | 15 |
roc | GPE | 15 |
rpcp fi | ORG | 15 |
rapamycin | GPE | 15 |
respiratory failure | DISEASE | 15 |
respiratory syndrome coronavirus 2 sars | DISEASE | 15 |
amino acid | CHEMICAL | 14 |
fio | CHEMICAL | 14 |
sc | ORG | 14 |
clin med | PERSON | 14 |
cough | DISEASE | 14 |
tissue damage | DISEASE | 14 |
trauma | DISEASE | 14 |
nms | ORG | 13 |
death | DISEASE | 13 |
ev | ORG | 13 |
ifn | ORG | 13 |
mmp | ORG | 13 |
coronavirus disease | DISEASE | 13 |
scs | ORG | 13 |
calcium | CHEMICAL | 13 |
cardiovascular diseases | DISEASE | 13 |
lactate | CHEMICAL | 13 |
myocardial injury | DISEASE | 13 |
sepsis | DISEASE | 13 |
covid 19 | PERSON | 12 |
pdr | ORG | 12 |
kcdc | PERSON | 12 |
inflammation | DISEASE | 12 |
gi | ORG | 12 |
bame | ORG | 12 |
clostridium difficile infection | DISEASE | 12 |
crc | ORG | 12 |
ai | ORG | 12 |
acei arb | ORG | 12 |
paclitaxel | ORG | 12 |
poland | GPE | 12 |
qt | PERSON | 12 |
south korea | GPE | 12 |
angiotensin aldosterone | CHEMICAL | 12 |
bats | TAXON | 12 |
febrile | DISEASE | 12 |
infarct | DISEASE | 12 |
mitochondrial dysfunction | DISEASE | 12 |
steroid | CHEMICAL | 12 |
the world health organization | ORG | 12 |
tumors | DISEASE | 12 |
sirolimus rapamycin | PERSON | 12 |
ibd | ORG | 11 |
uc | GPE | 11 |
tgf | ORG | 11 |
l n | LOC | 11 |
ii | ORG | 11 |
cdc | DISEASE | 11 |
hi | DISEASE | 11 |
hcq | ORG | 11 |
h1n1 | GPE | 11 |
chronic obstructive pulmonary disease | DISEASE | 11 |
chronic diseases | DISEASE | 11 |
ecmo | ORG | 11 |
colorectal cancer | DISEASE | 11 |
man | TAXON | 11 |
comorbidity | DISEASE | 11 |
the united states | GPE | 11 |
respiratory syndrome | DISEASE | 11 |
miscarriage | DISEASE | 11 |
respiratory disease | DISEASE | 11 |
infected | DISEASE | 11 |
gut microbiota | PERSON | 11 |
dyspnea | DISEASE | 11 |
diabetic | DISEASE | 11 |
ggt | ORG | 10 |
ps | ORG | 10 |
ppe | CHEMICAL | 10 |
pcr | ORG | 10 |
octa | ORG | 10 |
lsds | DISEASE | 10 |
bws | ORG | 10 |
comorbidity | DISEASE | 10 |
cvds | DISEASE | 10 |
ritonavir | PERSON | 10 |
cr | ORG | 10 |
aki | DISEASE | 10 |
rf | ORG | 10 |
spasticity | DISEASE | 10 |
spss | ORG | 10 |
respiratory distress | DISEASE | 10 |
volume reduction | DISEASE | 10 |
vascular invasion | DISEASE | 10 |
the robert koch institute | ORG | 10 |
respiratory syndrome coronavirus | DISEASE | 10 |
acute lung injury | DISEASE | 10 |
rat | TAXON | 10 |
movement disorder | DISEASE | 10 |
metabolic syndrome | DISEASE | 10 |
brain injury | DISEASE | 10 |
multisystem inflammatory syndrome | DISEASE | 10 |
ibs | ORG | 9 |
mesenchymal | GPE | 9 |
mod | ORG | 9 |
mis | ORG | 9 |
kidney | PERSON | 9 |
kawasaki disease | DISEASE | 9 |
kaplan meier | PERSON | 9 |
kap | ORG | 9 |
igm iga | ORG | 9 |
ilc2 | CHEMICAL | 9 |
gdm | ORG | 9 |
hydroxychloroquine | CHEMICAL | 9 |
fu | ORG | 9 |
england | GPE | 9 |
coronavirus infected pneumonia | DISEASE | 9 |
mice | TAXON | 9 |
cap | PERSON | 9 |
cir | ORG | 9 |
azithromycin | GPE | 9 |
australia | GPE | 9 |
chronic obstructive pulmonary disease | DISEASE | 9 |
pa | ORG | 9 |
north italy | LOC | 9 |
hypoxemia | DISEASE | 9 |
vivo | GPE | 9 |
thrombosis | DISEASE | 9 |
steroids | CHEMICAL | 9 |
social dysfunction | DISEASE | 9 |
polyp | DISEASE | 9 |
portugal | GPE | 9 |
lymphopenia | DISEASE | 9 |
infectious diseases | DISEASE | 9 |
infectious | DISEASE | 9 |
nitric oxide | CHEMICAL | 9 |
diarrhea | DISEASE | 9 |
coronavirus infections | DISEASE | 9 |
bacteria | TAXON | 9 |
acute respiratory distress syndrome | DISEASE | 9 |
usa | GPE | 9 |
stroke | PERSON | 9 |
rhinovirus | TAXON | 9 |
prevalence | ORG | 9 |
coronavirus pneumonia | DISEASE | 9 |
mitochondria | GPE | 8 |
il 6 | ORG | 8 |
individuals | TAXON | 8 |
lps | ORG | 8 |
heart failure | DISEASE | 8 |
neoguide | ORG | 8 |
neuromuscular | ORG | 8 |
os | ORG | 8 |
hypoxemia | DISEASE | 8 |
respiratory distress syndrome | DISEASE | 8 |
everolimus rad001 | PERSON | 8 |
deaths | DISEASE | 8 |
chlamydia | TAXON | 8 |
chitosan | ORG | 8 |
cfr | ORG | 8 |
asp | ORG | 8 |
anova | ORG | 8 |
als | DISEASE | 8 |
ad | DISEASE | 8 |
ova | ORG | 8 |
murine | TAXON | 8 |
singapore | GPE | 8 |
viral proteins | TAXON | 8 |
wii fit | PERSON | 8 |
ulcerative colitis | DISEASE | 8 |
theophylline | CHEMICAL | 8 |
skin lesions | DISEASE | 8 |
respiratory diseases | DISEASE | 8 |
parathyroid adenoma | DISEASE | 8 |
pancreatitis | DISEASE | 8 |
myocarditis | DISEASE | 8 |
respiratory syndrome mers | DISEASE | 8 |
metformin | CHEMICAL | 8 |
hosts | TAXON | 8 |
fatigue | DISEASE | 8 |
coronavirus covid | DISEASE | 8 |
chronic kidney disease | DISEASE | 8 |
chronic disease | DISEASE | 8 |
adenoma | DISEASE | 8 |
acute respiratory syndrome sars | DISEASE | 8 |
injury | DISEASE | 8 |
mip | ORG | 7 |
isncsci motor | ORG | 7 |
korea | GPE | 7 |
mbi | ORG | 7 |
mct | ORG | 7 |
neurokinex | ORG | 7 |
mmat | ORG | 7 |
molecular | ORG | 7 |
mouse | TAXON | 7 |
nacl | CHEMICAL | 7 |
hcov nl63 | PERSON | 7 |
humans | TAXON | 7 |
ckd | ORG | 7 |
ggo | PERSON | 7 |
fdp | ORG | 7 |
ert | ORG | 7 |
dif | ORG | 7 |
coagulopathy | DISEASE | 7 |
chronic | ORG | 7 |
cardiovascular disease | DISEASE | 7 |
cancer | DISEASE | 7 |
ca | CHEMICAL | 7 |
pr | ORG | 7 |
asymptomatic | PERSON | 7 |
ali ards | DISEASE | 7 |
oxphos | ORG | 7 |
ml | PERSON | 7 |
rpcp | ORG | 7 |
human proteins | TAXON | 7 |
rti | ORG | 7 |
worm | TAXON | 7 |
thrombocytopenia | GPE | 7 |
shock | DISEASE | 7 |
rhinovirus | TAXON | 7 |
peripheral arterial disease | DISEASE | 7 |
mitophagy | CHEMICAL | 7 |
mitochondria | GPE | 7 |
malignancy | DISEASE | 7 |
intravascular coagulation | DISEASE | 7 |
interstitial pneumonia | DISEASE | 7 |
inflammatory multisystem syndrome | DISEASE | 7 |
pathologies | DISEASE | 7 |
human coronavirus | TAXON | 7 |
thailand | GPE | 7 |
sinave | ORG | 7 |
host | TAXON | 7 |
sma | ORG | 7 |
savana | PERSON | 7 |
smoking | CHEMICAL | 7 |
autoimmunity | DISEASE | 7 |
avian | TAXON | 7 |
dysbiosis | DISEASE | 7 |
fractures | DISEASE | 7 |
neuromuscular disorder | DISEASE | 6 |
new york city | GPE | 6 |
selamectin | ORG | 6 |
ptsd symptomatology | DISEASE | 6 |
poisson | PERSON | 6 |
ros | ORG | 6 |
results | PERSON | 6 |
taiwan | GPE | 6 |
spike | ORG | 6 |
systematic | LOC | 6 |
t2d | DISEASE | 6 |
table 1 | LOC | 6 |
thrombosis | DISEASE | 6 |
univariate | ORG | 6 |
n 1015 | ORG | 6 |
niv | ORG | 6 |
canada | GPE | 6 |
mortality | DISEASE | 6 |
dysphagia | ORG | 6 |
acute cholangitis | DISEASE | 6 |
ang2 | ORG | 6 |
baseline | ORG | 6 |
ct | GPE | 6 |
csa | ORG | 6 |
dp | GPE | 6 |
fecal | ORG | 6 |
li | PERSON | 6 |
geneva | GPE | 6 |
hdac | ORG | 6 |
hubei | GPE | 6 |
il 2 | ORG | 6 |
injury | ORG | 6 |
kidney disease | DISEASE | 6 |
wce | ORG | 6 |
heart disease | DISEASE | 6 |
acute respiratory syndrome | DISEASE | 6 |
lung diseases | DISEASE | 6 |
myopia | DISEASE | 6 |
necrosis | DISEASE | 6 |
nucleic acid | CHEMICAL | 6 |
omalizumab | CHEMICAL | 6 |
organisms | TAXON | 6 |
plaque | DISEASE | 6 |
pregnancy loss | DISEASE | 6 |
procalcitonin | CHEMICAL | 6 |
rats | TAXON | 6 |
respiratory illness | DISEASE | 6 |
syncytial virus | TAXON | 6 |
the world health organization who | ORG | 6 |
thromboembolic | DISEASE | 6 |
aligners | CHEMICAL | 6 |
thrombotic | DISEASE | 6 |
myocardial ischemia | DISEASE | 6 |
pulmonary embolism | DISEASE | 6 |
human coronaviruses | TAXON | 6 |
confusion | DISEASE | 6 |
arrhythmias | DISEASE | 6 |
human cells | TAXON | 6 |
apomorphine | PERSON | 6 |
atrial fibrillation | DISEASE | 6 |
bat | TAXON | 6 |
cardiovascular | GPE | 6 |
biliary colic | DISEASE | 6 |
coronavirus sars cov | DISEASE | 6 |
coronavirus infected pneumonia | DISEASE | 6 |
corticosteroids | CHEMICAL | 6 |
gain | DISEASE | 6 |
heparin | CHEMICAL | 6 |
honoraria | GPE | 6 |
liguria | LOC | 5 |
pain | DISEASE | 5 |
mri | ORG | 5 |
leptin | PERSON | 5 |
microbiota | TAXON | 5 |
nhw | ORG | 5 |
nvi | DISEASE | 5 |
notch1 | GPE | 5 |
nrf2 | ORG | 5 |
pai | ORG | 5 |
sars cov 2 infection | DISEASE | 5 |
prasad | ORG | 5 |
rsv infection | DISEASE | 5 |
ratg13 | TAXON | 5 |
respiratory syndrome coronavirus 2 sars | DISEASE | 5 |
resveratrol | PERSON | 5 |
sars coronavirus | DISEASE | 5 |
si | ORG | 5 |
switzerland | GPE | 5 |
isth | GPE | 5 |
tat | ORG | 5 |
iran | GPE | 5 |
covid19 | ORG | 5 |
il 17 | ORG | 5 |
clostridium difficile infection | DISEASE | 5 |
teleorthodontics | ORG | 5 |
adm | ORG | 5 |
angiotensin aldosterone | CHEMICAL | 5 |
angiotensin ii | CHEMICAL | 5 |
anxiety | DISEASE | 5 |
asthma | GPE | 5 |
burnout | ORG | 5 |
cpet | ORG | 5 |
cardiovascular | PERSON | 5 |
coping | DISEASE | 5 |
ihc | ORG | 5 |
cord injury | DISEASE | 5 |
dbc | ORG | 5 |
enterobacteriaceae | PERSON | 5 |
epidemic | DISEASE | 5 |
grover s disease | DISEASE | 5 |
hrv infection | DISEASE | 5 |
hamming | PERSON | 5 |
hong kong | GPE | 5 |
hz | PERSON | 5 |
tslp | ORG | 5 |
mammalian | TAXON | 5 |
ORG | 5 | |
organ dysfunction | DISEASE | 5 |
lipopolysaccharide | CHEMICAL | 5 |
lung disease | DISEASE | 5 |
macrolide | CHEMICAL | 5 |
melatonin | CHEMICAL | 5 |
metabolic disorders | DISEASE | 5 |
multiorgan | GPE | 5 |
neutrophil | GPE | 5 |
nucleotide | CHEMICAL | 5 |
nucleotides | CHEMICAL | 5 |
perforation | DISEASE | 5 |
leptin | PERSON | 5 |
pig | TAXON | 5 |
preeclampsia | DISEASE | 5 |
respiratory failure septic shock | DISEASE | 5 |
sodium | CHEMICAL | 5 |
somatic symptoms | DISEASE | 5 |
tremor | DISEASE | 5 |
tumor necrosis | DISEASE | 5 |
vascular leakage | DISEASE | 5 |
zambon | PERSON | 5 |
levodopa | PERSON | 5 |
tumor | DISEASE | 5 |
inflammatory disease | DISEASE | 5 |
critically ill covid | DISEASE | 5 |
immunocompromised | DISEASE | 5 |
angiotensin i | CHEMICAL | 5 |
bilirubin | CHEMICAL | 5 |
burnout syndrome | DISEASE | 5 |
cerebrovascular disease | DISEASE | 5 |
chronic heart failure | DISEASE | 5 |
comorbid | DISEASE | 5 |
coronavirus 2019 ncov infections | DISEASE | 5 |
cortisol | CHEMICAL | 5 |
allergic rhinitis | DISEASE | 5 |
dermatitis | DISEASE | 5 |
host cell | TAXON | 5 |
hypercoagulation | DISEASE | 5 |
exacerbations | DISEASE | 5 |
house | TAXON | 5 |
alcohol | CHEMICAL | 5 |
gastrointestinal symptoms | DISEASE | 5 |
feces | TAXON | 5 |
functional impairment | DISEASE | 5 |
fibrin | TAXON | 5 |
nucleocapsid | ORG | 4 |
notably | ORG | 4 |
netherlands | GPE | 4 |
np | ORG | 4 |
nl13892 | ORG | 4 |
nad | ORG | 4 |
n 4509 | ORG | 4 |
motol | GPE | 4 |
mann whitney u | PERSON | 4 |
madrid | GPE | 4 |
loc | ORG | 4 |
macario | CHEMICAL | 4 |
mof | ORG | 4 |
mds updrs iii | ORG | 4 |
lymphopenia | PERSON | 4 |
lombardia | GPE | 4 |
lessons | ORG | 4 |
laboratory | GPE | 4 |
orthodontic | GPE | 4 |
mip 2 | ORG | 4 |
respiratory syndrome | DISEASE | 4 |
outcomes | ORG | 4 |
pbs | ORG | 4 |
kgf | ORG | 4 |
south italy | LOC | 4 |
stai | ORG | 4 |
srt2104 | ORG | 4 |
sf 36 | ORG | 4 |
savana | ORG | 4 |
sars cov 2 infection | DISEASE | 4 |
sars cov mers cov | ORG | 4 |
rift | TAXON | 4 |
respiratory syndrome coronavirus | DISEASE | 4 |
renin angiotensin aldosterone system | PERSON | 4 |
plasma | GPE | 4 |
parkinson disease | DISEASE | 4 |
parkinson | DISEASE | 4 |
paris fire brigade | ORG | 4 |
prrs | CHEMICAL | 4 |
pic | ORG | 4 |
ktx | ORG | 4 |
chicago | GPE | 4 |
js | PERSON | 4 |
balf | ORG | 4 |
castilla la mancha | PERSON | 4 |
cardiovascular disease | DISEASE | 4 |
ctc | CHEMICAL | 4 |
cse | ORG | 4 |
cs | ORG | 4 |
crp | ORG | 4 |
cmos | ORG | 4 |
ce | GPE | 4 |
associations | ORG | 4 |
ipf | ORG | 4 |
arenaviridae | TAXON | 4 |
akt | ORG | 4 |
auc | ORG | 4 |
arbs | CHEMICAL | 4 |
ag | CHEMICAL | 4 |
ace inhibitors | CHEMICAL | 4 |
aca | ORG | 4 |
tf | ORG | 4 |
challenges | ORG | 4 |
clínic | DISEASE | 4 |
colonosleeve | ORG | 4 |
dbs | ORG | 4 |
il 1 | ORG | 4 |
ids | ORG | 4 |
hsp | PERSON | 4 |
htn | ORG | 4 |
ghq | ORG | 4 |
gcsf | ORG | 4 |
frankfurt | GPE | 4 |
france | GPE | 4 |
fcγr | ORG | 4 |
everolimus | ORG | 4 |
electro | GPE | 4 |
eu | ORG | 4 |
etc | ORG | 4 |
disease x | ORG | 4 |
dt | PERSON | 4 |
dpg | CHEMICAL | 4 |
dgs | ORG | 4 |
staphylococcus | CHEMICAL | 4 |
mitochondrial dysfunction | DISEASE | 4 |
tai chi | PERSON | 4 |
lupus | DISEASE | 4 |
pigs | TAXON | 4 |
pathogen disease | DISEASE | 4 |
neuronal death | DISEASE | 4 |
neoplasia | DISEASE | 4 |
melanoma | DISEASE | 4 |
mammals | TAXON | 4 |
malnutrition | DISEASE | 4 |
macaque | TAXON | 4 |
liver disorders | DISEASE | 4 |
human body | TAXON | 4 |
isocitrate | CHEMICAL | 4 |
ischemic heart disease | DISEASE | 4 |
infarction | DISEASE | 4 |
imidazole | CHEMICAL | 4 |
idiopathic | DISEASE | 4 |
ibuprofen | CHEMICAL | 4 |
hyperplasia | DISEASE | 4 |
hyperparathyroidism | DISEASE | 4 |
pregnancy complications | DISEASE | 4 |
prostate cancer | DISEASE | 4 |
psychological distress | DISEASE | 4 |
pulmonary edema | DISEASE | 4 |
βcov | ORG | 4 |
virus infection | DISEASE | 4 |
viral genome | TAXON | 4 |
vancomycin | CHEMICAL | 4 |
urea | CHEMICAL | 4 |
type 2 diabetes | DISEASE | 4 |
thrombotic complications | DISEASE | 4 |
the u s | GPE | 4 |
the huanan seafood wholesale market | ORG | 4 |
swine | TAXON | 4 |
shortness of breath | DISEASE | 4 |
s opening remarks | PERSON | 4 |
rheumatoid arthritis | DISEASE | 4 |
respiratory infections | DISEASE | 4 |
pulmonary vascular leakage alveolar edema | DISEASE | 4 |
pulmonary infiltrates | DISEASE | 4 |
pulmonary emboli | DISEASE | 4 |
hypercoagulability | DISEASE | 4 |
respiratory infection | DISEASE | 4 |
hepatopathy | DISEASE | 4 |
anxiety disorders | DISEASE | 4 |
cardiovascular disorders | DISEASE | 4 |
cardiovascular complications | DISEASE | 4 |
bradycardia | GPE | 4 |
birds | TAXON | 4 |
bat sars | DISEASE | 4 |
atherosclerosis | DISEASE | 4 |
asthmatic | DISEASE | 4 |
arrhythmia | DISEASE | 4 |
alveolar dysfunction | DISEASE | 4 |
chest pain | DISEASE | 4 |
alanine | CHEMICAL | 4 |
abruptio | DISEASE | 4 |
wuhan city | GPE | 4 |
wu | GPE | 4 |
viral rna | TAXON | 4 |
tumor | DISEASE | 4 |
trauma | DISEASE | 4 |
gaps | DISEASE | 4 |
cerebrovascular diseases | DISEASE | 4 |
allergic | DISEASE | 4 |
coma | DISEASE | 4 |
disability | DISEASE | 4 |
fumarate | CHEMICAL | 4 |
coronavirus 2019 ncov | DISEASE | 4 |
failure | DISEASE | 4 |
faeces | TAXON | 4 |
excitotoxicity | DISEASE | 4 |
endothelial dysfunction | DISEASE | 4 |
edema | DISEASE | 4 |
diseases | DISEASE | 4 |
endotheliitis | DISEASE | 4 |
disabilities | DISEASE | 4 |
dexamethasone | CHEMICAL | 4 |
thrombocytopenia | GPE | 4 |
dengue | DISEASE | 4 |
dementia | DISEASE | 4 |
delirium | DISEASE | 4 |
coronavirus 2019 ncov infection | DISEASE | 4 |
coronavirus infection | DISEASE | 4 |
north west | GPE | 3 |
neutrophilic | ORG | 3 |
new york | GPE | 3 |
north | LOC | 3 |
north america | LOC | 3 |
overweight | DISEASE | 3 |
orf1ab | ORG | 3 |
omalizumab | CHEMICAL | 3 |
pd networks | ORG | 3 |
pai 1 | ORG | 3 |
prr | ORG | 3 |
navicam | ORG | 3 |
neurotrauma | CHEMICAL | 3 |
metformin | GPE | 3 |
nasopharyngeal | ORG | 3 |
nse | ORG | 3 |
ncbi | ORG | 3 |
nadh | ORG | 3 |
myocarditis | DISEASE | 3 |
multisystem inflammatory syndrome | ORG | 3 |
milan | GPE | 3 |
middle east respiratory syndrome coronavirus | LOC | 3 |
metabolic syndrome | DISEASE | 3 |
meta analysis | ORG | 3 |
meta | ORG | 3 |
pao | ORG | 3 |
melatonin | CHEMICAL | 3 |
ptm | ORG | 3 |
serum | GPE | 3 |
paris | GPE | 3 |
praevia | CHEMICAL | 3 |
mrsa | ORG | 3 |
studies | ORG | 3 |
spearman | PERSON | 3 |
sliker | CHEMICAL | 3 |
skills | PERSON | 3 |
single | ORG | 3 |
shapiro wilk | ORG | 3 |
severity | GPE | 3 |
sendai | ORG | 3 |
sarabien | TAXON | 3 |
san francisco | GPE | 3 |
san diego | GPE | 3 |
sofa | ORG | 3 |
sirt | ORG | 3 |
serocov | CHEMICAL | 3 |
sars cov 2 infection | DISEASE | 3 |
sars cov 2 igm | ORG | 3 |
roche | ORG | 3 |
ribavirin | PERSON | 3 |
respiratory syndrome coronavirus 2 infection | DISEASE | 3 |
respiratory infection | DISEASE | 3 |
respiratory failure | DISEASE | 3 |
renin | PERSON | 3 |
pseudomonas aeruginosa | TAXON | 3 |
pregnancy loss | DISEASE | 3 |
mt | CHEMICAL | 3 |
compassion | ORG | 3 |
mas | ORG | 3 |
endorings | ORG | 3 |
desulfovibrio | PERSON | 3 |
deep | PERSON | 3 |
dallas | GPE | 3 |
drs | ORG | 3 |
dcs | ORG | 3 |
corticosteroids | PERSON | 3 |
coronavirus ncov infection | DISEASE | 3 |
coronavirus 2019 ncov pneumonia | DISEASE | 3 |
coronaviridae | ORG | 3 |
corno | LOC | 3 |
teff | PERSON | 3 |
casa | ORG | 3 |
cambridge | GPE | 3 |
cbd | ORG | 3 |
biliary | GPE | 3 |
bcl 2 | PERSON | 3 |
bscs | LOC | 3 |
avian coronaviruses | TAXON | 3 |
asthma exacerbations | ORG | 3 |
antiphospholipid | DISEASE | 3 |
ais c stim | ORG | 3 |
aids | DISEASE | 3 |
ace 2 expression | CHEMICAL | 3 |
ace | ORG | 3 |
a systematic review | ORG | 3 |
ebola virus | TAXON | 3 |
exacerbations of asthma | DISEASE | 3 |
lopinavir ritonavir | CHEMICAL | 3 |
gmp | CHEMICAL | 3 |
likert | PERSON | 3 |
lus | ORG | 3 |
limc a | CHEMICAL | 3 |
kawasaki disease | DISEASE | 3 |
jbi | ORG | 3 |
jak | ORG | 3 |
jaam dic | ORG | 3 |
j clin med | PERSON | 3 |
intensive care unit | ORG | 3 |
innovative | ORG | 3 |
imagenet | ORG | 3 |
iga igm | ORG | 3 |
iop | ORG | 3 |
il 10 | ORG | 3 |
ibm | ORG | 3 |
huanan | GPE | 3 |
histologic | ORG | 3 |
healthcare | ORG | 3 |
hansa | ORG | 3 |
hrqol | PERSON | 3 |
hiv infected | DISEASE | 3 |
gut microbiota | PERSON | 3 |
graphpad prism | ORG | 3 |
gastrocnemius gs | PERSON | 3 |
gp | ORG | 3 |
tbi 71 | PERSON | 3 |
mers cov infection | DISEASE | 3 |
time | ORG | 3 |
microbiome | TAXON | 3 |
pulmonary disease | DISEASE | 3 |
psychological disorders | DISEASE | 3 |
potassium | CHEMICAL | 3 |
porcine | TAXON | 3 |
parkinsonism | DISEASE | 3 |
parathyroid tumors | DISEASE | 3 |
opacities | DISEASE | 3 |
neurodegenerative diseases | DISEASE | 3 |
necrotic | DISEASE | 3 |
myocardial inflammation | DISEASE | 3 |
multisystem diseases | DISEASE | 3 |
microbiota | TAXON | 3 |
mice transgenic | TAXON | 3 |
human respiratory disease | DISEASE | 3 |
metabolic disorder | DISEASE | 3 |
metabolic diseases | DISEASE | 3 |
macrolides | CHEMICAL | 3 |
lymphocytopenia | DISEASE | 3 |
loss of oro naso sensory ons | DISEASE | 3 |
liver injury | DISEASE | 3 |
liver disease | DISEASE | 3 |
intravascular coagulation dic | DISEASE | 3 |
influenza like illness | DISEASE | 3 |
inflammatory syndrome | DISEASE | 3 |
inflammatory diseases | DISEASE | 3 |
inflammatory bowel disease | DISEASE | 3 |
pulmonary infection | DISEASE | 3 |
renal failure | DISEASE | 3 |
respiratory symptoms | DISEASE | 3 |
respiratory syndrome coronavirus mers | DISEASE | 3 |
tocilizumab | CHEMICAL | 3 |
vomiting | DISEASE | 3 |
virus disease | DISEASE | 3 |
viral protein | TAXON | 3 |
viral genomes | TAXON | 3 |
ventricular tachycardia | DISEASE | 3 |
ventricular fibrillation | DISEASE | 3 |
vasculitis | DISEASE | 3 |
traumatic stress disorder | DISEASE | 3 |
the university hospital | ORG | 3 |
the endotics system | ORG | 3 |
tensin | CHEMICAL | 3 |
technetium 99 | CHEMICAL | 3 |
tandem | ORG | 3 |
tacrolimus | CHEMICAL | 3 |
symptomatology | DISEASE | 3 |
succinate | CHEMICAL | 3 |
statins | CHEMICAL | 3 |
silicone | CHEMICAL | 3 |
septic shock | DISEASE | 3 |
rodents | TAXON | 3 |
rigidity | DISEASE | 3 |
ribavirin | CHEMICAL | 3 |
rhinovirus infection | DISEASE | 3 |
respiratory tract infections | DISEASE | 3 |
hypertension cerebrovascular diseases | DISEASE | 3 |
thiazolidinediones | CHEMICAL | 3 |
acute kidney injury | DISEASE | 3 |
aneurysm | DISEASE | 3 |
bpm | ORG | 3 |
bloodstream | DISEASE | 3 |
bleeding | DISEASE | 3 |
bile duct stones | DISEASE | 3 |
avian influenza | PERSON | 3 |
autoimmune diseases | DISEASE | 3 |
autoimmune disease | DISEASE | 3 |
asthma a | DISEASE | 3 |
aspartate | CHEMICAL | 3 |
antimetabolite | CHEMICAL | 3 |
anosmia | DISEASE | 3 |
angiotensin 1 7 by | CHEMICAL | 3 |
anakinra | CHEMICAL | 3 |
chickenpox | DISEASE | 3 |
allergic diseases | DISEASE | 3 |
allergic airway inflammation | DISEASE | 3 |
adenomas | DISEASE | 3 |
acute respiratory syndrome coronavirus infection | DISEASE | 3 |
acute respiratory failure arf | DISEASE | 3 |
acute myocardial infarction | DISEASE | 3 |
acute coronary syndrome | DISEASE | 3 |
abdominal pain | DISEASE | 3 |
youden | GPE | 3 |
wuhan hubei | GPE | 3 |
viruses | TAXON | 3 |
host organism | TAXON | 3 |
camels | TAXON | 3 |
anxiety depression | DISEASE | 3 |
chilblains | CHEMICAL | 3 |
dying | DISEASE | 3 |
heat shock | DISEASE | 3 |
headache | DISEASE | 3 |
glutamate | CHEMICAL | 3 |
glucocorticoids | CHEMICAL | 3 |
cholestasis | DISEASE | 3 |
fits | DISEASE | 3 |
everolimus | CHEMICAL | 3 |
endotoxemia | DISEASE | 3 |
endothelial damage | DISEASE | 3 |
empathy | DISEASE | 3 |
eclampsia | DISEASE | 3 |
dyslipidemia | DISEASE | 3 |
gestational diabetes mellitus | DISEASE | 3 |
disorders | DISEASE | 3 |
conflict | DISEASE | 3 |
creatine | CHEMICAL | 3 |
cognitive disorders | DISEASE | 3 |
cognitive impairment | DISEASE | 3 |
complaint | DISEASE | 3 |
complexity | DISEASE | 3 |
colonic polyps | DISEASE | 3 |
convalescent | DISEASE | 3 |
coagulation | DISEASE | 3 |
coronary artery disease | DISEASE | 3 |
coronaviruses | TAXON | 3 |
leung | PERSON | 2 |
l n ratio | CHEMICAL | 2 |
linear | ORG | 2 |
legionellosis | ORG | 2 |
lee et al | PERSON | 2 |
lack | PERSON | 2 |
lopd | ORG | 2 |
ld | GPE | 2 |
lcig | CHEMICAL | 2 |
la | CHEMICAL | 2 |
l n ratio and parathyroid | CHEMICAL | 2 |
kidney disorder cardiac disease | DISEASE | 2 |
l n max 2 78 | CHEMICAL | 2 |
kruskal wallis | LOC | 2 |
kim | PERSON | 2 |
kidney injury | DISEASE | 2 |
ki67 | ORG | 2 |
khatri | GPE | 2 |
keratinocyte | PERSON | 2 |
kawasaki | ORG | 2 |
k k | ORG | 2 |
liver disease | DISEASE | 2 |
jochen | CHEMICAL | 2 |
lipoteichoic acid | ORG | 2 |
gaucher disease | DISEASE | 2 |
living treatment centers | ORG | 2 |
mary obese | PERSON | 2 |
microbes | TAXON | 2 |
italy a | DISEASE | 2 |
methylprednisolone | CHEMICAL | 2 |
metapneumovirus | CHEMICAL | 2 |
medicare | ORG | 2 |
mechanisms | GPE | 2 |
mazowieckie province | GPE | 2 |
mayhew et al | PERSON | 2 |
maternal | ORG | 2 |
mas | ORG | 2 |
marco | CHEMICAL | 2 |
logistic | PERSON | 2 |
manzoni | PERSON | 2 |
maas | PERSON | 2 |
mlhfq | ORG | 2 |
mers cov genomic data | ORG | 2 |
mdr | ORG | 2 |
mdc | ORG | 2 |
lupus | DISEASE | 2 |
lung | PERSON | 2 |
lucinda obese | PERSON | 2 |
loss | PERSON | 2 |
jasp | ORG | 2 |
hutchinson | PERSON | 2 |
ishmael | GPE | 2 |
ich | DISEASE | 2 |
huntington s disease | DISEASE | 2 |
huntington | GPE | 2 |
human rhinovirus | TAXON | 2 |
huh7 | ORG | 2 |
hospital | ORG | 2 |
hokkaido | GPE | 2 |
heparin | CHEMICAL | 2 |
hematological | GPE | 2 |
healthy people | PERSON | 2 |
hpai | ORG | 2 |
hku1 | TAXON | 2 |
hdm | ORG | 2 |
h5n1 | TAXON | 2 |
h n | ORG | 2 |
grünenthal | CHEMICAL | 2 |
gloucestershire uk | PERSON | 2 |
glasgow coma scale | ORG | 2 |
genova | ORG | 2 |
genotype | PERSON | 2 |
gender differences | PERSON | 2 |
middle east respiratory syndrome | LOC | 2 |
hypothetical | ORG | 2 |
ics | ORG | 2 |
iscan coreo | CHEMICAL | 2 |
ifn λ | CHEMICAL | 2 |
invendo medical | ORG | 2 |
intuitive surgical inc | ORG | 2 |
intravascular coagulation | DISEASE | 2 |
intensive care units icu | ORG | 2 |
intensive care units | ORG | 2 |
information motivation behavioural skills | ORG | 2 |
influenza | ORG | 2 |
inflammatory bowel disease | DISEASE | 2 |
infectious disease | DISEASE | 2 |
india | GPE | 2 |
incidence | ORG | 2 |
iga vasculitis | DISEASE | 2 |
iso | CHEMICAL | 2 |
isncsci | ORG | 2 |
isi | ORG | 2 |
inr | ORG | 2 |
imv | CHEMICAL | 2 |
il9 | ORG | 2 |
il 6 ferritin ldh | ORG | 2 |
il 5 | ORG | 2 |
iii | ORG | 2 |
microbiota transfer therapy | PERSON | 2 |
pityrosporum folliculitis | DISEASE | 2 |
mindfulness | ORG | 2 |
pseudomonas | GPE | 2 |
rpc | ORG | 2 |
rnfl | ORG | 2 |
rnaaemia | ORG | 2 |
rmsd | ORG | 2 |
rgs | ORG | 2 |
rer | ORG | 2 |
rcpch | ORG | 2 |
raw 264 7 | ORG | 2 |
pubmed | PERSON | 2 |
psychometric | PERSON | 2 |
prognosis | ORG | 2 |
parkinsonism | DISEASE | 2 |
prof krammer | PERSON | 2 |
pregnancy loss a | DISEASE | 2 |
pregnancy | GPE | 2 |
preeclampsia preeclampsia | LOC | 2 |
pompe | ORG | 2 |
pohl | PERSON | 2 |
period | CHEMICAL | 2 |
sars cov infection | DISEASE | 2 |
perinatal | ORG | 2 |
pearson s chi squared | ORG | 2 |
rpcp pd rnfl | ORG | 2 |
rrt | ORG | 2 |
rabbit coronavirus | TAXON | 2 |
rabbit coronavirus infection | DISEASE | 2 |
garden city hertfordshire | GPE | 2 |
sars cov sars cov | ORG | 2 |
sars cov 2 evolution 9 | ORG | 2 |
sars cov 2 sars cov 2 | ORG | 2 |
sar cov | ORG | 2 |
ruminococcaceae bacteroidaceae | ORG | 2 |
ruminococcaceae | CHEMICAL | 2 |
rotter | DISEASE | 2 |
rome | GPE | 2 |
roflumilast | CHEMICAL | 2 |
robotic | LOC | 2 |
rigidity | LOC | 2 |
rhinovirus infection | DISEASE | 2 |
rheumatoid arthritis | DISEASE | 2 |
rex | PERSON | 2 |
respiratory disease | DISEASE | 2 |
respiratory syndrome sars | DISEASE | 2 |
respiratory syndrome mers | DISEASE | 2 |
respiratory syndrome coronavirus mers | DISEASE | 2 |
respiratory infections | DISEASE | 2 |
renata | CHEMICAL | 2 |
participants | PERSON | 2 |
parkinson s syndrome | DISEASE | 2 |
mirhagi | TAXON | 2 |
n 1 85 0 84 | CHEMICAL | 2 |
new zealand | GPE | 2 |
navicam ankon technologies | ORG | 2 |
national institute for health and clinical excellence | ORG | 2 |
nasal polyps | PERSON | 2 |
nyha | ORG | 2 |
non stim | LOC | 2 |
non | ORG | 2 |
nlp | ORG | 2 |
nct04276987 | ORG | 2 |
na | ORG | 2 |
møller sørensen | PERSON | 2 |
parkinson s | DISEASE | 2 |
myocardial injury | DISEASE | 2 |
musculoskeletal injuries | DISEASE | 2 |
multimorbidity | DISEASE | 2 |
multicenter | PERSON | 2 |
movement disorder | DISEASE | 2 |
monte carlo | PERSON | 2 |
mitophagy | PERSON | 2 |
mitochondrial | LOC | 2 |
missing | LOC | 2 |
miro1 | CHEMICAL | 2 |
next | ORG | 2 |
nidovirales | GPE | 2 |
nishiura hiroshi | PERSON | 2 |
nitric oxide | CHEMICAL | 2 |
parkinson disease | DISEASE | 2 |
paraesthesia | GPE | 2 |
pangolin | CHEMICAL | 2 |
ptss | PERSON | 2 |
pheic | ORG | 2 |
pgd2 | ORG | 2 |
pei | GPE | 2 |
pd day | ORG | 2 |
p4 rta | CHEMICAL | 2 |
p4 ais | CHEMICAL | 2 |
p f ratio | ORG | 2 |
oxytocin | PERSON | 2 |
oseltamivir | ORG | 2 |
ortega | PERSON | 2 |
occupational | ORG | 2 |
obsessive compulsive | DISEASE | 2 |
ovesco endoscopy ag | ORG | 2 |
oct a | ORG | 2 |
nutalapati | CHEMICAL | 2 |
novel | GPE | 2 |
non | PERSON | 2 |
gaucher | PERSON | 2 |
antonella | CHEMICAL | 2 |
galván casas | PERSON | 2 |
bacterial orthologs | TAXON | 2 |
bone | ORG | 2 |
blue | ORG | 2 |
bifidobacterium prevotella | PERSON | 2 |
betacoronavirus | GPE | 2 |
bernth | ORG | 2 |
beijing | GPE | 2 |
behnke | ORG | 2 |
behavioural skills | ORG | 2 |
bayer ag | ORG | 2 |
barcelona | GPE | 2 |
bacteremia | PERSON | 2 |
aspergillus fumigatus | DISEASE | 2 |
backer | PERSON | 2 |
bp | GPE | 2 |
bdnf | PERSON | 2 |
bdi | ORG | 2 |
b cell lymphoma | DISEASE | 2 |
axelgard fallbrook ca united states | ORG | 2 |
autophagy | PERSON | 2 |
austria | GPE | 2 |
atlanta | GPE | 2 |
asymptomatic contact | PERSON | 2 |
bradykinesia | PERSON | 2 |
brazil | GPE | 2 |
breast cancer | DISEASE | 2 |
brisbane injury | ORG | 2 |
cvd stroke | DISEASE | 2 |
crc deaths | DISEASE | 2 |
cr programs | ORG | 2 |
cpr | ORG | 2 |
coronado | ORG | 2 |
copd exacerbations | DISEASE | 2 |
co2 | ORG | 2 |
cns | ORG | 2 |
cni | ORG | 2 |
cmv | DISEASE | 2 |
clever | ORG | 2 |
ckd coagulopathy | ORG | 2 |
chd | DISEASE | 2 |
cfs | DISEASE | 2 |
cfda | ORG | 2 |
cd123 | CHEMICAL | 2 |
cct | ORG | 2 |
ccb | ORG | 2 |
cave | ORG | 2 |
cad cvd | ORG | 2 |
ca usa | ORG | 2 |
asthmatic | DISEASE | 2 |
aspergillus | TAXON | 2 |
cambridge electronic design | ORG | 2 |
ag tübingen | CHEMICAL | 2 |
atg | ORG | 2 |
ast | ORG | 2 |
ards acute respiratory distress syndrome green | DISEASE | 2 |
ards acute | ORG | 2 |
arb ibuprofen | CHEMICAL | 2 |
apc | ORG | 2 |
amp | ORG | 2 |
alp | ORG | 2 |
ais a and c improvements | ORG | 2 |
ais a | PERSON | 2 |
afi | ORG | 2 |
asia | LOC | 2 |
ace ace i | CHEMICAL | 2 |
ace 2 | ORG | 2 |
acc | ORG | 2 |
a rapid systematic review | ORG | 2 |
7096 | CHEMICAL | 2 |
5363 | DISEASE | 2 |
5 1 4 5 days minimum 1 day | CHEMICAL | 2 |
4 nsp7 | CHEMICAL | 2 |
3d | ORG | 2 |
sbvs | ORG | 2 |
azm | ORG | 2 |
abnormal coagulation | DISEASE | 2 |
achilles | PERSON | 2 |
acute | GPE | 2 |
ashbaugh | ORG | 2 |
artificial | ORG | 2 |
anti c1q | PERSON | 2 |
annie obese | ORG | 2 |
angiotensinogen | ORG | 2 |
ang 1 mrna | PERSON | 2 |
ang 1 | PERSON | 2 |
analysis | PERSON | 2 |
analogue | ORG | 2 |
american thoracic society european respiratory society committee | ORG | 2 |
amber obese | LOC | 2 |
alzheimer s disease | DISEASE | 2 |
allergic asthmatic | LOC | 2 |
allergic airway disease | LOC | 2 |
aldosterone | CHEMICAL | 2 |
akhmetzhanov andrei | PERSON | 2 |
airway inflammation | DISEASE | 2 |
airway epithelial cells | ORG | 2 |
african caribbean | ORG | 2 |
africa | LOC | 2 |
addressing | PERSON | 2 |
california | GPE | 2 |
cardiac arrest | PERSON | 2 |
gscf | CHEMICAL | 2 |
eopd | ORG | 2 |
enterovirus | TAXON | 2 |
enterococci | CHEMICAL | 2 |
enterobacteriaceae veillonellaceae | PERSON | 2 |
enterobacteriaceae a | PERSON | 2 |
endocuff vision tm | PERSON | 2 |
elie metchnikoff | PERSON | 2 |
electron | ORG | 2 |
ebola virus infection | DISEASE | 2 |
early transmission dynamics | ORG | 2 |
exbio prague | ORG | 2 |
emr | ORG | 2 |
diagnosis | PERSON | 2 |
ef | ORG | 2 |
ee dp | ORG | 2 |
ecp | ORG | 2 |
ec | ORG | 2 |
e scooter accidents | CHEMICAL | 2 |
e coli bacteria | TAXON | 2 |
dyhor | CHEMICAL | 2 |
doxophylline | ORG | 2 |
disruption of mitophagy | ORG | 2 |
digitimer welwyn | PERSON | 2 |
eotaxin | PERSON | 2 |
epidemiological | ORG | 2 |
european centre for disease prevention | ORG | 2 |
european guidelines | ORG | 2 |
gromacs | ORG | 2 |
gm | ORG | 2 |
gee | CHEMICAL | 2 |
ge healthcare | ORG | 2 |
gdm gdm | PERSON | 2 |
ga | ORG | 2 |
g eye | ORG | 2 |
frozen | ORG | 2 |
formula | PERSON | 2 |
formosa | GPE | 2 |
flutracker | PERSON | 2 |
flu | TAXON | 2 |
febrile illness | DISEASE | 2 |
favipiravir t 705 | CHEMICAL | 2 |
fatty acid | CHEMICAL | 2 |
faecal | ORG | 2 |
ORG | 2 | |
fabry disease | DISEASE | 2 |
fabry | PERSON | 2 |
figo | ORG | 2 |
extracellular | ORG | 2 |
diet | ORG | 2 |
diabetic | DISEASE | 2 |
cardiac death | DISEASE | 2 |
chronic obstructive pulmonary disease | DISEASE | 2 |
complications | ORG | 2 |
comparative | ORG | 2 |
collinsella aerofaciens | PERSON | 2 |
collaborative european neurotrauma effectiveness research | ORG | 2 |
covzc45 | TAXON | 2 |
cluster | PERSON | 2 |
clostridioides difficile infection | DISEASE | 2 |
ciuti gastone | PERSON | 2 |
ci | ORG | 2 |
chronic obstructive pulmonary disease copd | DISEASE | 2 |
chronic obstructive pulmonary disease copd | DISEASE | 2 |
dhont | GPE | 2 |
china presenting characteristics comorbidities | ORG | 2 |
charlson comorbidity | ORG | 2 |
characteristics | ORG | 2 |
centre | LOC | 2 |
case fatality rate and characteristics of patients dying in relation | ORG | 2 |
cardiovascular implications | ORG | 2 |
cardiovascular diseases | DISEASE | 2 |
cardiac disease kidney disorder | DISEASE | 2 |
cardiac disease kidney disease | DISEASE | 2 |
cardiac disease | DISEASE | 2 |
computerized | ORG | 2 |
cornidovirineae | PERSON | 2 |
coronavirus 2019 ncov infections | DISEASE | 2 |
coronavirus covid | DISEASE | 2 |
desitin | GPE | 2 |
dental | ORG | 2 |
dehghani | GPE | 2 |
decade long structural studies of sars | ORG | 2 |
daegu city | GPE | 2 |
dtt | CHEMICAL | 2 |
dr cd8 t | CHEMICAL | 2 |
dm tm | PERSON | 2 |
d euclidean | PERSON | 2 |
d 9 | CHEMICAL | 2 |
cysteinyl thiol | ORG | 2 |
current status | PERSON | 2 |
crohn s disease | DISEASE | 2 |
crohn s | PERSON | 2 |
cox proportional hazard | TAXON | 2 |
cox | PERSON | 2 |
corticosteroid | GPE | 2 |
coronavirus sars cov | DISEASE | 2 |
coronavirus rna | TAXON | 2 |
coronavirus pneumonia | DISEASE | 2 |
coronavirus infection | DISEASE | 2 |
sarsr cov | ORG | 2 |
nct03901001 | CHEMICAL | 2 |
sc210 | CHEMICAL | 2 |
musculoskeletal injuries | DISEASE | 2 |
neurodegeneration | DISEASE | 2 |
neoplastic lesion | DISEASE | 2 |
nematodes | TAXON | 2 |
nausea | DISEASE | 2 |
n 2 | ORG | 2 |
myocardial disfunction | DISEASE | 2 |
myasthenia gravis | DISEASE | 2 |
myalgia | DISEASE | 2 |
musculoskeletal neuropsychiatric gastrointestinal renal and cardiovascular disorders | DISEASE | 2 |
musculoskeletal neuropsychiatric gastrointestinal renal | ORG | 2 |
multiplies | TAXON | 2 |
neurological disorders | DISEASE | 2 |
multiple sclerosis | DISEASE | 2 |
multiorgan failure mof | DISEASE | 2 |
multiorgan failure | DISEASE | 2 |
multi organ failure | DISEASE | 2 |
multi organ dysfunction | DISEASE | 2 |
mucosal damage | DISEASE | 2 |
mouse macrophages | TAXON | 2 |
mmhg | ORG | 2 |
mitochondrial diseases | DISEASE | 2 |
microvascular damage | DISEASE | 2 |
neurological disorder | DISEASE | 2 |
neuronal damage | DISEASE | 2 |
human coronavirus nl63 | TAXON | 2 |
overload | DISEASE | 2 |
plants | TAXON | 2 |
perianexial lymphocytic infiltration | DISEASE | 2 |
pathogen | ORG | 2 |
parathyroid carcinoma l n 2 02 1 29 p 0 | DISEASE | 2 |
paraquat | CHEMICAL | 2 |
paraplegia | DISEASE | 2 |
paralysis | DISEASE | 2 |
paraesthesia | GPE | 2 |
pangolins | TAXON | 2 |
pain dyspnoea dysphagia | DISEASE | 2 |
oseltamivir | CHEMICAL | 2 |
neutrophilia | DISEASE | 2 |
organ dysfunction syndrome | DISEASE | 2 |
organ damage | DISEASE | 2 |
olfactory dysfunction | DISEASE | 2 |
obesity impaired cognition | DISEASE | 2 |
obese | DISEASE | 2 |
nsp14 | ORG | 2 |
nsp12 | CHEMICAL | 2 |
nonrespiratory symptoms | DISEASE | 2 |
nicotinamide adenine | ORG | 2 |
neutrophilic airway | ORG | 2 |
methyl cytosine phosphate guanine | CHEMICAL | 2 |
metabolic disease | DISEASE | 2 |
meta | CHEMICAL | 2 |
increases in volitional muscle | DISEASE | 2 |
interferon ifn | CHEMICAL | 2 |
injury premorbid psychiatric | DISEASE | 2 |
inflammatory damages | DISEASE | 2 |
infiltration | DISEASE | 2 |
infectious pathogens | DISEASE | 2 |
infectious bronchitis | DISEASE | 2 |
infection of heart tissue | DISEASE | 2 |
infection coronavirus disease | DISEASE | 2 |
infected with coronavirus | DISEASE | 2 |
infected person coughs or sneezes | DISEASE | 2 |
incessant | DISEASE | 2 |
meningism | DISEASE | 2 |
impairment | DISEASE | 2 |
immune disorder | DISEASE | 2 |
idiopathic arthritis | DISEASE | 2 |
hypotension | DISEASE | 2 |
hypertension cardiopathy coronaropathy chronic renal failure chronic obstructive pulmonary disease diabetes mellitus obesity stroke | DISEASE | 2 |
hypertension atrial fibrillation | DISEASE | 2 |
hyperglycemia | DISEASE | 2 |
hydrogen peroxide | CHEMICAL | 2 |
human respiratory epithelial cells | TAXON | 2 |
human monocytes | TAXON | 2 |
intracerebral bleeding | DISEASE | 2 |
intravascular coagulopathy | DISEASE | 2 |
irritable bowel syndrome | DISEASE | 2 |
ischemic heart disease peripheral vascular disease | DISEASE | 2 |
mammalian cells | TAXON | 2 |
malocclusion | DISEASE | 2 |
mm tris | PERSON | 2 |
lysosomal disorders | DISEASE | 2 |
lymphadenopathy | DISEASE | 2 |
lung prostate pancreas breast colon | DISEASE | 2 |
lung parenchymal abnormalities | DISEASE | 2 |
lung injuries | DISEASE | 2 |
lung inflammation | DISEASE | 2 |
lung dysfunctions | DISEASE | 2 |
lung damage | DISEASE | 2 |
lung and heart injuries | DISEASE | 2 |
loss of taste and smell | DISEASE | 2 |
loss of smell or taste | DISEASE | 2 |
loss of olfactory sensory | DISEASE | 2 |
loss of consciousness | DISEASE | 2 |
labor | DISEASE | 2 |
kettle bell | PERSON | 2 |
ketamine | CHEMICAL | 2 |
juvantibus therapy | PERSON | 2 |
journal | ORG | 2 |
ponatinib | GPE | 2 |
pranlukast | CHEMICAL | 2 |
pregnancy loss a | DISEASE | 2 |
thrombus | DISEASE | 2 |
undue complications | DISEASE | 2 |
uk uk | ORG | 2 |
tyrosine | CHEMICAL | 2 |
type 2 diabetes mellitus | DISEASE | 2 |
triacylglycerol tag | CHEMICAL | 2 |
traumatic symptomatology | DISEASE | 2 |
traumatic amnesia | DISEASE | 2 |
traffic accidents | DISEASE | 2 |
toxicity | DISEASE | 2 |
toxic shock syndrome | DISEASE | 2 |
thrombopoietin | ORG | 2 |
the perceived stress scale | ORG | 2 |
thrombophilic disorders | DISEASE | 2 |
thrombocytopenia lymphopenia c | DISEASE | 2 |
thrombi | DISEASE | 2 |
these environmental factors | ORG | 2 |
the hospital s research commission | ORG | 2 |
the wuhan municipal health commission | ORG | 2 |
the world health organization 17 | ORG | 2 |
the united kingdom | GPE | 2 |
the sars cov | ORG | 2 |
the republic of korea | GPE | 2 |
urinary tract infections pneumonia toxic shock syndrome | DISEASE | 2 |
urticarial eruptions | DISEASE | 2 |
valve heart disease | DISEASE | 2 |
vascular disorders | DISEASE | 2 |
weight gain | DISEASE | 2 |
sci 25 | ORG | 2 |
viruses bacteria | TAXON | 2 |
viruses adenoviruses | TAXON | 2 |
virus genome | TAXON | 2 |
virtual colon | DISEASE | 2 |
viral transmembrane | TAXON | 2 |
viral infiltration | DISEASE | 2 |
viral genome sequences | TAXON | 2 |
viral antibody | TAXON | 2 |
viral rna polymerases | TAXON | 2 |
viral rna polymerase | TAXON | 2 |
violaceus | TAXON | 2 |
vessel stroke | DISEASE | 2 |
versión | CHEMICAL | 2 |
ventricular arrhythmias | DISEASE | 2 |
venous thrombosis | DISEASE | 2 |
venous thromboembolism | DISEASE | 2 |
venous thromboembolic | DISEASE | 2 |
vasculopathic | DISEASE | 2 |
vascular invasion p 0 0377 figure 3 | DISEASE | 2 |
the preferred reporting items for systematic reviews | ORG | 2 |
the national health commission of china | ORG | 2 |
pregnancy loss rpl | DISEASE | 2 |
respiratory decompensation | DISEASE | 2 |
shame | DISEASE | 2 |
septicemia | DISEASE | 2 |
roflumilast | CHEMICAL | 2 |
ritonavir | CHEMICAL | 2 |
rhinosinusitis | DISEASE | 2 |
retractions arf | DISEASE | 2 |
retinal impairment | DISEASE | 2 |
respiratory viruses | TAXON | 2 |
respiratory tract infection | DISEASE | 2 |
respiratory syncytial virus infection | DISEASE | 2 |
renal dysfunction | DISEASE | 2 |
the mixed method assessment tool | ORG | 2 |
reduced left ventricular ejection | DISEASE | 2 |
rapamycin | CHEMICAL | 2 |
rabbits | TAXON | 2 |
pulmonary restricted intravascular coagulopathy | DISEASE | 2 |
pulmonary diseases | DISEASE | 2 |
psychiatric disorders | DISEASE | 2 |
psoriasis | DISEASE | 2 |
prothrombotic disorder | DISEASE | 2 |
prostaglandin e | CHEMICAL | 2 |
propranolol | CHEMICAL | 2 |
sistemática prevalence | PERSON | 2 |
sleep disturbance | DISEASE | 2 |
sleep disturbances | DISEASE | 2 |
snakes | TAXON | 2 |
the middle east | LOC | 2 |
the mazowieckie province | GPE | 2 |
the institutional review board irb | ORG | 2 |
the institutional ethics committee | ORG | 2 |
the european society of cardiology and other societies on cardiovascular disease prevention | ORG | 2 |
the european association for cardiovascular prevention | ORG | 2 |
the ethical committee | ORG | 2 |
the day hospital | ORG | 2 |
the centers for disease control and prevention | ORG | 2 |
the cxr co score | ORG | 2 |
thank | CHEMICAL | 2 |
taste dysfunction | DISEASE | 2 |
tachycardia | DISEASE | 2 |
swab specimens | PERSON | 2 |
succinylcholine | CHEMICAL | 2 |
subdural hematomas | DISEASE | 2 |
subarachnoidal bleeding | DISEASE | 2 |
stent occlusion | DISEASE | 2 |
steatosis | DISEASE | 2 |
somatization | DISEASE | 2 |
sodium chloride | CHEMICAL | 2 |
human diseases | DISEASE | 2 |
the american heart association | ORG | 2 |
herpes zoster | PERSON | 2 |
uk ltd | ORG | 2 |
virus disease | DISEASE | 2 |
vircell igm iga | CHEMICAL | 2 |
viral infection | DISEASE | 2 |
vero | PERSON | 2 |
ventricular arrhythmias | DISEASE | 2 |
varicella | DISEASE | 2 |
valvular regurgitation | DISEASE | 2 |
vte | DISEASE | 2 |
united states | GPE | 2 |
ulcerative colitis | DISEASE | 2 |
tÜv | ORG | 2 |
texas | GPE | 2 |
troponin | PERSON | 2 |
treg | GPE | 2 |
tracker | PERSON | 2 |
toronto | GPE | 2 |
tokyo | GPE | 2 |
thromboembolic | DISEASE | 2 |
thomas | PERSON | 2 |
the world health organization who | ORG | 2 |
the sixth joint task force | ORG | 2 |
the international weight management | ORG | 2 |
wang et al | PERSON | 2 |
warsaw | GPE | 2 |
weight gain | DISEASE | 2 |
wii balance board nintendo co ltd | ORG | 2 |
acute respiratory failure | DISEASE | 2 |
acute respiratory distress | DISEASE | 2 |
acute respiratory disease syndrome ards | DISEASE | 2 |
acute renal failure | DISEASE | 2 |
acute myocardial injury | DISEASE | 2 |
acute myocardial infarction ami | DISEASE | 2 |
acute lung failure angiotensin | DISEASE | 2 |
acute lung failure | DISEASE | 2 |
acute kidney injury aki acute respiratory syndrome ards | DISEASE | 2 |
acute ischemic stroke | DISEASE | 2 |
acute heart failure | DISEASE | 2 |
acute cerebrovascular disease | DISEASE | 2 |
acute bacterial infection | DISEASE | 2 |
acid | CHEMICAL | 2 |
accidents | DISEASE | 2 |
ziekenhuis oost limburg | PERSON | 2 |
zhou et al | PERSON | 2 |
zambon valeant desitin | PERSON | 2 |
wuhan city | GPE | 2 |
wuhan shanghai | PERSON | 2 |
wuhan coronavirus | PERSON | 2 |
the centers for disease control and prevention | ORG | 2 |
tan | PERSON | 2 |
adenosine triphosphate atp | CHEMICAL | 2 |
srt1720 | CHEMICAL | 2 |
severe acute respiratory syndrome sars | ORG | 2 |
severe acute respiratory syndrome coronavirus | ORG | 2 |
septic | DISEASE | 2 |
sensitivity | ORG | 2 |
sendai virus | TAXON | 2 |
screen kit | PERSON | 2 |
savona figure | ORG | 2 |
savona | PERSON | 2 |
svm | ORG | 2 |
svh | ORG | 2 |
spid | ORG | 2 |
table s4 | PERSON | 2 |
spet | GPE | 2 |
sl | ORG | 2 |
sirt1 | PERSON | 2 |
sirs | ORG | 2 |
seir | ORG | 2 |
sdoh | ORG | 2 |
scim | GPE | 2 |
sci of | ORG | 2 |
hepatitis | DISEASE | 2 |
sci worldwide | ORG | 2 |
shea | PERSON | 2 |
shirin | PERSON | 2 |
shown | PERSON | 2 |
signal | ORG | 2 |
table 3 | LOC | 2 |
trl | ORG | 2 |
tree | ORG | 2 |
tbi injury | ORG | 2 |
tbi gcs 13 | ORG | 2 |
tbi gcs | CHEMICAL | 2 |
tbi 59 | PERSON | 2 |
tag | ORG | 2 |
tac | ORG | 2 |
systematic reviews | GPE | 2 |
syncytial virus | TAXON | 2 |
swine | TAXON | 2 |
sutterella | PERSON | 2 |
streptococcus | GPE | 2 |
steyerberg | GPE | 2 |
state | ORG | 2 |
srl | CHEMICAL | 2 |
specimens | ORG | 2 |
south east | LOC | 2 |
social | ORG | 2 |
sirolimus | CHEMICAL | 2 |
acute respiratory syndrome coronavirus 2 sars cov 2 infection | DISEASE | 2 |
statistical package for social sciences | ORG | 2 |
aggressiveness | DISEASE | 2 |
disorder | DISEASE | 2 |
encephalomyelitis | DISEASE | 2 |
encephalitis | DISEASE | 2 |
emotional distress | DISEASE | 2 |
electrocardiographic abnormalities 123 the injury | DISEASE | 2 |
electro goniometers | PERSON | 2 |
ectasia | PERSON | 2 |
dysphasia | DISEASE | 2 |
dysphagia | ORG | 2 |
drug eruption | DISEASE | 2 |
distal | ORG | 2 |
diabetes hypertension | DISEASE | 2 |
endothelial cell dysfunction | DISEASE | 2 |
depressed | DISEASE | 2 |
darunavir ritonavir | CHEMICAL | 2 |
cyclosporine | CHEMICAL | 2 |
cyanosis | DISEASE | 2 |
cutaneous lesions | DISEASE | 2 |
critically ill covid | DISEASE | 2 |
craniocerebral trauma | DISEASE | 2 |
coworkers | CHEMICAL | 2 |
cough dyspnea | DISEASE | 2 |
coronavirus 2019 ncov pneumonia | DISEASE | 2 |
encephalopathy | DISEASE | 2 |
enteric pathogens clostridium difficile | TAXON | 2 |
coronary heart disease | DISEASE | 2 |
fracture | DISEASE | 2 |
hemorrhage | DISEASE | 2 |
heart muscle | DISEASE | 2 |
heart injury | DISEASE | 2 |
aggressiveness of parathyroid carcinomas | DISEASE | 2 |
head injuries | DISEASE | 2 |
goblet cell hyperplasia squamous metaplasia | DISEASE | 2 |
glycemia | DISEASE | 2 |
glaucoma | DISEASE | 2 |
gestational diabetes | DISEASE | 2 |
gadolinium | CHEMICAL | 2 |
formaldehyde | CHEMICAL | 2 |
eruptions | DISEASE | 2 |
fever dry cough | DISEASE | 2 |
ferritin d dimers | PERSON | 2 |
ferritin | GPE | 2 |
ferrets | TAXON | 2 |
fatty acid | CHEMICAL | 2 |
fatigue burnout | DISEASE | 2 |
exanthema | DISEASE | 2 |
eukaryotic viral | TAXON | 2 |
eubiosis | CHEMICAL | 2 |
etomidate | CHEMICAL | 2 |
coronary ischemia | DISEASE | 2 |
falls | DISEASE | 2 |
corona virus disease | DISEASE | 2 |
appendicitis | DISEASE | 2 |
cancer a | DISEASE | 2 |
ctn | ORG | 2 |
bronchopulmonary dysplasia | DISEASE | 2 |
breast milk | DISEASE | 2 |
bradykinesia | DISEASE | 2 |
bovine | TAXON | 2 |
biliary lesion | DISEASE | 2 |
biliary injury | DISEASE | 2 |
bacterial lymphadenitis viral illness | DISEASE | 2 |
asystole | DISEASE | 2 |
angiotensinaldosterone | CHEMICAL | 2 |
cardiac arrest | DISEASE | 2 |
angiotensin ii ang ii | CHEMICAL | 2 |
angiotensin 1 7 | CHEMICAL | 2 |
aneurysms | DISEASE | 2 |
androgens | CHEMICAL | 2 |
analgesia | GPE | 2 |
airway hyperreactivity | DISEASE | 2 |
conjunctivitis | DISEASE | 2 |
amino acids | CHEMICAL | 2 |
airway infection | DISEASE | 2 |
aluminum | CHEMICAL | 2 |
carcinogenesis | DISEASE | 2 |
asthma active smoking systolic blood pressure | DISEASE | 2 |
cardiac arrest heart failure cardiomyopathies hypertension atherosclerosis | DISEASE | 2 |
cholecystitis | DISEASE | 2 |
colonic flexures | DISEASE | 2 |
colchicine | CHEMICAL | 2 |
colonoscope electric | ORG | 2 |
cardiac injuries | DISEASE | 2 |
colorectal cancer crc | DISEASE | 2 |
concomitant pregnancy complications | DISEASE | 2 |
coagulation disorders | DISEASE | 2 |
clazakizumab anakinra | PERSON | 2 |
chronic respiratory diseases | DISEASE | 2 |
chronic obstructive pulmonary disease copd | DISEASE | 2 |
chronic motor complete and incomplete | ORG | 2 |
chronic respiratory disease | DISEASE | 2 |
cerebral hemorrhage | DISEASE | 2 |
chloroquine | CHEMICAL | 2 |
cardiovascular comorbidities | DISEASE | 2 |
chaperonopathies | CHEMICAL | 2 |
cerebrovascular stroke | DISEASE | 2 |
cardiovascular complication | DISEASE | 2 |
cerebral ischemia | DISEASE | 2 |
cardiovascular disease hypertension diabetes | DISEASE | 2 |
learn | PERSON | 1 |
lastly | ORG | 1 |
lateropulsion | ORG | 1 |
latino sexual | DISEASE | 1 |
lattanzi | GPE | 1 |
laura rizzelli | PERSON | 1 |
laura alamon reig francesc iranzo | ORG | 1 |
lee jung eun mcdonough | PERSON | 1 |
laura signori alessio | PERSON | 1 |
lehamann | CHEMICAL | 1 |
leg movement | ORG | 1 |
laplace | ORG | 1 |
leaner | PERSON | 1 |
lasprilla | CHEMICAL | 1 |
lachnospiraceae | CHEMICAL | 1 |
lang et al values | PERSON | 1 |
lancet transmission | ORG | 1 |
lox | ORG | 1 |
lm | ORG | 1 |
lrm | ORG | 1 |
leng | PERSON | 1 |
limc smoking | CHEMICAL | 1 |
lsd | CHEMICAL | 1 |
ltc 4 | ORG | 1 |
lte4 | CHEMICAL | 1 |
la | PERSON | 1 |
laboratori guidotti | PERSON | 1 |
lachnospiraceae 29 | ORG | 1 |
lack of association of ischemic heart | ORG | 1 |
lactate | CHEMICAL | 1 |
lactobacillaceae | PERSON | 1 |
laiene | CHEMICAL | 1 |
lena sand dorothea berges | ORG | 1 |
liver gastrointestinal | ORG | 1 |
length | PERSON | 1 |
lengthen | CHEMICAL | 1 |
liver gastrointestinal tract sars | DISEASE | 1 |
liver impairment | DISEASE | 1 |
liver injury | DISEASE | 1 |
liza cleary | PERSON | 1 |
lodi | GPE | 1 |
log | PERSON | 1 |
long term | ORG | 1 |
long term safety of endoscopic biliary stents | ORG | 1 |
long term spinal cord stimulation | ORG | 1 |
lop riton | PERSON | 1 |
lopinavir ritonavir lopinavir ritonavir | CHEMICAL | 1 |
lorena barboza gudagnini | PERSON | 1 |
lham | ORG | 1 |
lopinavir ritonavir treatment arms | PERSON | 1 |
lopinavir ritonavir | CHEMICAL | 1 |
lisbon metropolitan area | ORG | 1 |
lipopolysaccharide | CHEMICAL | 1 |
lipid | GPE | 1 |
lightweight | ORG | 1 |
levy | LOC | 1 |
li volti giovanni | ORG | 1 |
li et al 3 | PERSON | 1 |
lichermt gmbh | ORG | 1 |
licochalcone a | CHEMICAL | 1 |
ligand | GPE | 1 |
likewise goldberg | PERSON | 1 |
linton natalie m kobayashi | PERSON | 1 |
limburg flemish | GPE | 1 |
limburg genk belgium | GPE | 1 |
limited somatic mutation iga | ORG | 1 |
lin qianying | PERSON | 1 |
linee | CHEMICAL | 1 |
linton natalie m kinoshita | PERSON | 1 |
liaf lega italiana | ORG | 1 |
kaho | CHEMICAL | 1 |
ldh | ORG | 1 |
kalathiya | PERSON | 1 |
k akt | ORG | 1 |
k g | ORG | 1 |
k t n m k | CHEMICAL | 1 |
kb | PERSON | 1 |
kcdc classification ii | ORG | 1 |
kadah | DISEASE | 1 |
kamran | CHEMICAL | 1 |
juszczyk | CHEMICAL | 1 |
kanishka | GPE | 1 |
karachi coping | PERSON | 1 |
karolina marlicz | PERSON | 1 |
kato et al | PERSON | 1 |
katsuma | CHEMICAL | 1 |
kaufman | PERSON | 1 |
juvenile idiopathic arthritis | DISEASE | 1 |
jung sung mok kinoshita ryo thompson robin n | PERSON | 1 |
kawasaki disease novel virus and novel case guillain barre | ORG | 1 |
juan carlos zavan barbara | PERSON | 1 |
joon sup | GPE | 1 |
joonyong jung | PERSON | 1 |
lorenzl stefan | PERSON | 1 |
josé m | ORG | 1 |
jouffroy | CHEMICAL | 1 |
jouffroy romain | PERSON | 1 |
juan carlos zeldovich | PERSON | 1 |
jung sung mok | PERSON | 1 |
judith wilson | PERSON | 1 |
juergen | DISEASE | 1 |
julia | ORG | 1 |
jun n | ORG | 1 |
jun nterminal | ORG | 1 |
jun yong | PERSON | 1 |
kawada masahiro fujimi satoshi | PERSON | 1 |
kawasaki like disease | DISEASE | 1 |
la 28 3 | ORG | 1 |
kuba | PERSON | 1 |
koch s postulates | PERSON | 1 |
kolmogorov smirnov | PERSON | 1 |
konate | CHEMICAL | 1 |
korea practical | ORG | 1 |
korogiannou maria grigorakos konstantinos papalois vassilios boletis ioannis | PERSON | 1 |
krankheitsbild morbus | PERSON | 1 |
kudo et al 55 | PERSON | 1 |
kobo | CHEMICAL | 1 |
kuniya toshikazu | PERSON | 1 |
kuriakose | GPE | 1 |
kvaal et al 14 | PERSON | 1 |
l e r and s l s r | CHEMICAL | 1 |
l m | ORG | 1 |
l n value lesion | CHEMICAL | 1 |
kobo toolbox | ORG | 1 |
kobayashi tetsuro | PERSON | 1 |
kawasaki like multisystem inflammatory syndrome | DISEASE | 1 |
kidney and liver transplant | DISEASE | 1 |
kazuhiro ito | PERSON | 1 |
keap 1 | ORG | 1 |
keulen | PERSON | 1 |
khan amira sayed | PERSON | 1 |
kidney disease | DISEASE | 1 |
kidney neuromuscular | PERSON | 1 |
kidney disorder | DISEASE | 1 |
klucken | ORG | 1 |
kidney disorders | DISEASE | 1 |
kidney infection | DISEASE | 1 |
kim byung jun jang | PERSON | 1 |
kim jinuoung jeong | PERSON | 1 |
kinect | PERSON | 1 |
klouche | CHEMICAL | 1 |
lorenzl | CHEMICAL | 1 |
mazumdar madhu | CHEMICAL | 1 |
lorenzo hernández | PERSON | 1 |
lorrain | DISEASE | 1 |
matan moshe | CHEMICAL | 1 |
maternal coronavirus | PERSON | 1 |
maternal fetal transmission | ORG | 1 |
maternal implications of pregnancy complications | ORG | 1 |
mathworks inc natick ma usa | PERSON | 1 |
matthew a | PERSON | 1 |
mayordomo marcos | PERSON | 1 |
małgorzata nicholson | PERSON | 1 |
mcfadden s pseudo | PERSON | 1 |
mechanisms and management of asthma exacerbations precision medicine and phenotypes endotypes genotypes regiotypes | ORG | 1 |
media | ORG | 1 |
medicaid beneficiaries | PERSON | 1 |
medical device regulation european union | ORG | 1 |
medicine committee international parkinson | ORG | 1 |
medikus | PERSON | 1 |
massimo polosa riccardo | PERSON | 1 |
massimo | GPE | 1 |
mass index | ORG | 1 |
marinaki smaragdi | PERSON | 1 |
mao | PERSON | 1 |
mapping systemic inflammation and antibody responses | ORG | 1 |
mar barcelona | PERSON | 1 |
marc belarte | PERSON | 1 |
marco lavitrano marialuisa faravelli | PERSON | 1 |
marinaki | CHEMICAL | 1 |
markov | ORG | 1 |
mascaró josé | CHEMICAL | 1 |
marks parkinson | PERSON | 1 |
marrugat | CHEMICAL | 1 |
marta nataya | ORG | 1 |
mary | PERSON | 1 |
mary ryan | PERSON | 1 |
marzano | PERSON | 1 |
medikus leaves | PERSON | 1 |
mediterranean | LOC | 1 |
medline | ORG | 1 |
microsoft | ORG | 1 |
mig | CHEMICAL | 1 |
mice genetic | TAXON | 1 |
michael lorrain | PERSON | 1 |
michele massimo gelsomino sandro | PERSON | 1 |
michigan | GPE | 1 |
micro thrombosis | ORG | 1 |
middle | LOC | 1 |
mexico 62 | GPE | 1 |
middle east respiratory syndrome mers covs | LOC | 1 |
middle east | LOC | 1 |
miguel ancochea | PERSON | 1 |
miguel costa | PERSON | 1 |
johns hopkins coronavirus resource center | ORG | 1 |
milano italy | PERSON | 1 |
meylan france | PERSON | 1 |
mexico | GPE | 1 |
melatonin s | GPE | 1 |
merylin mazza | PERSON | 1 |
melissa pronold | PERSON | 1 |
memo mag total | ORG | 1 |
mental | ORG | 1 |
mepolizumab a | CHEMICAL | 1 |
merkler | PERSON | 1 |
merylin | TAXON | 1 |
meseznikov | CHEMICAL | 1 |
methods single | ORG | 1 |
metabolic syndrome induces release of smaller extracellular vesicles | PERSON | 1 |
metabolic syndrome interferes with packaging of proteins | ORG | 1 |
metabolic diseases | DISEASE | 1 |
metastasis | DISEASE | 1 |
method asymptomatic | PERSON | 1 |
methods plasma | PERSON | 1 |
manuel gómez huelgas ricardo | PERSON | 1 |
manuel di | PERSON | 1 |
manuel | ORG | 1 |
mcp1 mip1a | PERSON | 1 |
lysosomal storage diseases | DISEASE | 1 |
m livovsky dan nubani adi | PERSON | 1 |
ma usa | ORG | 1 |
maoa | ORG | 1 |
map | ORG | 1 |
matlab | ORG | 1 |
mers cov htcc broad | ORG | 1 |
lynsey d | PERSON | 1 |
mers cov potential | ORG | 1 |
mers cov sars cov | ORG | 1 |
mers cov studies | ORG | 1 |
mers cov recombination | ORG | 1 |
mers infection | DISEASE | 1 |
mhc | ORG | 1 |
lysosomal | PERSON | 1 |
lymphopenia 53 | PERSON | 1 |
mip 1a | CHEMICAL | 1 |
lumbreras | CHEMICAL | 1 |
loss guideline | PERSON | 1 |
loss of smell and taste | DISEASE | 1 |
loss of taste | DISEASE | 1 |
louisiana | GPE | 1 |
luis fernando grandcourtova | PERSON | 1 |
lumbosacral spinal cord epidural stimulation for standing after chronic complete paralysis | ORG | 1 |
lung injury | DISEASE | 1 |
lymphocytosis bacterial | ORG | 1 |
lung disorders | DISEASE | 1 |
lupus erythematosus | DISEASE | 1 |
luís márcia abrantes | PERSON | 1 |
lymphangiogenesis in parathyroid proliferative lesions immunohistochemistry | ORG | 1 |
lymphocyte | ORG | 1 |
lymphocytosis | DISEASE | 1 |
mhv | TAXON | 1 |
mip 1α | CHEMICAL | 1 |
mann whitney | PERSON | 1 |
malaysia | GPE | 1 |
macaca fascicularis reflectance | PERSON | 1 |
macario alberto jl | PERSON | 1 |
macronutrient mediated inflammation and oxidative stress relevance to insulin resistance obesity | ORG | 1 |
macular cube | ORG | 1 |
madhu kohli seth roopa | PERSON | 1 |
magro | ORG | 1 |
malpractice | ORG | 1 |
msm | ORG | 1 |
mammalian | TAXON | 1 |
management of parkinson s disease | ORG | 1 |
management of severe acute respiratory infection | ORG | 1 |
manami matsuda | PERSON | 1 |
mandall | PERSON | 1 |
manfredi et al | PERSON | 1 |
mac | PERSON | 1 |
msd outside | ORG | 1 |
mip 1β | CHEMICAL | 1 |
modeller mega | CHEMICAL | 1 |
mip1a | PERSON | 1 |
mip1alpha ccl3 | PERSON | 1 |
mis c report | ORG | 1 |
mle | ORG | 1 |
mn908947 | CHEMICAL | 1 |
mo | GPE | 1 |
momp | ORG | 1 |
msd italia | ORG | 1 |
mpa | ORG | 1 |
mpo | ORG | 1 |
mps | DISEASE | 1 |
mri images | ORG | 1 |
mri molecular breast imaging | ORG | 1 |
mrsa vancomycin | CHEMICAL | 1 |
johns hopkins coronavirus resource center clinical characteristics | ORG | 1 |
hospital clínic de barcelona | ORG | 1 |
jodie | CHEMICAL | 1 |
jochen warnecke tobias buhmann carsten | PERSON | 1 |
hospitals | LOC | 1 |
hot | CHEMICAL | 1 |
houston | GPE | 1 |
hsp60 | DISEASE | 1 |
hsp60 post | ORG | 1 |
hu | PERSON | 1 |
huang | PERSON | 1 |
hubei province | GPE | 1 |
human asthmatic airways respiratory | ORG | 1 |
human bronchial smooth muscle cells exposed | ORG | 1 |
human cd8 memory t cells | ORG | 1 |
human cells | TAXON | 1 |
human leukocyte | TAXON | 1 |
human rhinovirus species | TAXON | 1 |
human virus | TAXON | 1 |
hospitalized | ORG | 1 |
hospitalization rates and characteristics of patients hospitalized with laboratory | ORG | 1 |
hospitalization | LOC | 1 |
hodges lehamann | PERSON | 1 |
hinxton cambridge | GPE | 1 |
hiromi shinya | PERSON | 1 |
hironori | DISEASE | 1 |
hiroshi | PERSON | 1 |
hisprep | CHEMICAL | 1 |
histone | ORG | 1 |
holi | ORG | 1 |
hospital del | ORG | 1 |
holm | ORG | 1 |
holm bonferroni | PERSON | 1 |
home | PERSON | 1 |
homes results | PERSON | 1 |
hong kong respiratory support for patients with | ORG | 1 |
mild | GPE | 1 |
human antibodies | TAXON | 1 |
human coronaviruses | TAXON | 1 |
human immunodeficiency virus hiv furthermore blood | DISEASE | 1 |
iemest | ORG | 1 |
ibm armonk ny usa 2020 | ORG | 1 |
ibv | ORG | 1 |
iccp | ORG | 1 |
icd | ORG | 1 |
ictv | ORG | 1 |
iem | ORG | 1 |
iemest everly conway de macario | ORG | 1 |
ibd irritable bowel syndrome ibs | DISEASE | 1 |
ieo | ORG | 1 |
ies r | ORG | 1 |
ifn i | CHEMICAL | 1 |
ifn gamma tnf il 23 il 15 il 21 | CHEMICAL | 1 |
ifn β | PERSON | 1 |
ifn2 | PERSON | 1 |
ibm armonk ny usa | ORG | 1 |
hypothyroidism | DISEASE | 1 |
human mesenchymal stem cell microvesicles | TAXON | 1 |
hyperinflammatory syndrome | DISEASE | 1 |
human rhinovirus infection | DISEASE | 1 |
humans epidural | LOC | 1 |
hydraulic | ORG | 1 |
hyperarousal | PERSON | 1 |
hyperarousal irritated | DISEASE | 1 |
hypercoagulability | DISEASE | 1 |
hyperinflammatory shock | DISEASE | 1 |
hyposmia | GPE | 1 |
hyperlipidemic | ORG | 1 |
hypermetabolism | DISEASE | 1 |
hypertension cerebrovascular disease | DISEASE | 1 |
hypertension diabetes cvd | DISEASE | 1 |
hypoalbuminemia | DISEASE | 1 |
hyponatremia | DISEASE | 1 |
hindlimb | ORG | 1 |
higher | PERSON | 1 |
high fractional | ORG | 1 |
hrafter | GPE | 1 |
hlh | CHEMICAL | 1 |
hpv | ORG | 1 |
hpv immunization celiac disease | DISEASE | 1 |
hr spo 2 | ORG | 1 |
hrp samples | ORG | 1 |
hrv a | ORG | 1 |
hrbefore | PERSON | 1 |
hiv positive kidney transplant recipient successful recovery | DISEASE | 1 |
htcc | CHEMICAL | 1 |
hts fda | ORG | 1 |
haas juergen | PERSON | 1 |
haemostasis diagnosis | ORG | 1 |
hamburg | GPE | 1 |
handbook of robotics endoscopy | ORG | 1 |
hku1 oc43 sars mers | DISEASE | 1 |
hiv infections | DISEASE | 1 |
hansa et al | PERSON | 1 |
hif | ORG | 1 |
hcovs | CHEMICAL | 1 |
hd | DISEASE | 1 |
hf action | ORG | 1 |
hf trials towards | ORG | 1 |
hf and atrial fibrillation | DISEASE | 1 |
hfnc | ORG | 1 |
himc cxr | ORG | 1 |
hiv infection | DISEASE | 1 |
hiv 1 infected | DISEASE | 1 |
hiv 1 infection | DISEASE | 1 |
hiv esc guidelines | ORG | 1 |
hiv hot spot survey of stress | ORG | 1 |
hiv protease inhibitors | ORG | 1 |
hiv individuals | TAXON | 1 |
hannah mccann | PERSON | 1 |
happy hypoxemia | DISEASE | 1 |
higgin s | PERSON | 1 |
hepatic encephalopathy | DISEASE | 1 |
helicobacter | PERSON | 1 |
hematologic | ORG | 1 |
hematological phenotype | PERSON | 1 |
hemostasis isth | ORG | 1 |
henan | GPE | 1 |
heparin induced thrombocytopenia covid 19 | ORG | 1 |
hepatitis virus | DISEASE | 1 |
healthy volunteers | PERSON | 1 |
hepatopathy | DISEASE | 1 |
hernández | CHEMICAL | 1 |
herruzo | DISEASE | 1 |
hessian | ORG | 1 |
heterogeneity | ORG | 1 |
hi | CHEMICAL | 1 |
heather | PERSON | 1 |
healthy mummy | PERSON | 1 |
harpaz rotem | PERSON | 1 |
health care | ORG | 1 |
hashimoto s thyroiditis t | DISEASE | 1 |
hasselt university | ORG | 1 |
hawkes | ORG | 1 |
hea nal rnfl | ORG | 1 |
head injuries | DISEASE | 1 |
health | ORG | 1 |
health care interventions checklist and explanations updated | ORG | 1 |
health systems | ORG | 1 |
health care personnel | ORG | 1 |
health care workers | ORG | 1 |
health committee s report on unexplained viral pneumonia novel human virus pneumonia cases linked to seafood market | ORG | 1 |
health diplomat | ORG | 1 |
health participation | ORG | 1 |
health psychol linking | PERSON | 1 |
igc | ORG | 1 |
ihc 23 | ORG | 1 |
ihc compared | ORG | 1 |
invendo medical gmbh | ORG | 1 |
interventions | GPE | 1 |
intimacy | ORG | 1 |
intimacy sexual activity orgasm | DISEASE | 1 |
intrusion | ORG | 1 |
intubation kit intubation team | ORG | 1 |
intubation spots consensus guidelines for managing the airway in patients with | ORG | 1 |
invendoscope sc40 | PERSON | 1 |
intervention for obesity a case series | ORG | 1 |
ioanna micali linda renata matteucci francesco lucà | PERSON | 1 |
iran multisystem | ORG | 1 |
irregular | ORG | 1 |
ischemic | LOC | 1 |
ischemic stroke | PERSON | 1 |
issues of cardiovascular risk management | ORG | 1 |
interventional | ORG | 1 |
international standards for neurological classification of spinal cord injury isncsci | ORG | 1 |
istituto diganostico varelli medical center | ORG | 1 |
interim clinical guidance for management of patients with confirmed coronavirus disease covid 19 abnormal | ORG | 1 |
integrated care | ORG | 1 |
intensive care | ORG | 1 |
intensive care unit icu susceptibility | ORG | 1 |
interestingly radford | PERSON | 1 |
interferon | ORG | 1 |
interim | ORG | 1 |
interleukin 1ra levels | ORG | 1 |
international parkinson and movement disorder society | ORG | 1 |
internal external locus of control scale | ORG | 1 |
international classification of diseases 11th | ORG | 1 |
international concern 68 | ORG | 1 |
international federation of gynecology and obstetrics postpregnancy | ORG | 1 |
international labour office ilo bit workplace stress a collective | ORG | 1 |
international labour organization workplace stress a collective challenge patient | ORG | 1 |
istituto diagnostico varelli medical center | ORG | 1 |
italy 119 | DISEASE | 1 |
innate lymphoid cells | ORG | 1 |
japan usa | ORG | 1 |
jmcr | PERSON | 1 |
jpj surviving sepsis campaign society of critical care medicine care of the critically ill | ORG | 1 |
jane symonds taylor | PERSON | 1 |
janet mcdonagh | PERSON | 1 |
jankowski mateusz | PERSON | 1 |
japan detection | ORG | 1 |
jarosław wierzba waldemar | PERSON | 1 |
jhm | PERSON | 1 |
jean paul jung boris | PERSON | 1 |
jeong su jin chung won | PERSON | 1 |
jessa hospital | PERSON | 1 |
jiangsu province association | ORG | 1 |
jinjun yang | PERSON | 1 |
jochen klucken | PERSON | 1 |
jj et al | PERSON | 1 |
jd | PERSON | 1 |
italy 45 | GPE | 1 |
italy lodi | LOC | 1 |
italy acute stroke | DISEASE | 1 |
italy case fatality rate characteristics | ORG | 1 |
italy considering | ORG | 1 |
italy esge | ORG | 1 |
italy electro | ORG | 1 |
italy experimental | GPE | 1 |
italy one | DISEASE | 1 |
jasp a | CHEMICAL | 1 |
italy risk factors for mortality | ORG | 1 |
italy infected | DISEASE | 1 |
iterative | ORG | 1 |
its implication for public health interventions novel coronavirus outbreak | ORG | 1 |
jaam dic isth | ORG | 1 |
jak block | DISEASE | 1 |
inova | ORG | 1 |
innate | ORG | 1 |
ihc dif | ORG | 1 |
igg iga | ORG | 1 |
iaccarino | ORG | 1 |
iacovacci | CHEMICAL | 1 |
ibuprofen | CHEMICAL | 1 |
iceland | GPE | 1 |
idiopathic parkinson syndrome | DISEASE | 1 |
idiopathic perniosis | DISEASE | 1 |
igg iga igm | ORG | 1 |
iv the living treatment center | ORG | 1 |
igg igm iga c3 | ORG | 1 |
igg sars cov 2 | ORG | 1 |
igm merck | ORG | 1 |
illness | GPE | 1 |
imiquimod | CHEMICAL | 1 |
immediate psychological responses | ORG | 1 |
ivig | ORG | 1 |
iv mps | ORG | 1 |
immune homeostasis | GPE | 1 |
inf | ORG | 1 |
il 13 | ORG | 1 |
il 17a 118 | ORG | 1 |
il 4 | ORG | 1 |
il usa quantitative | ORG | 1 |
il25 | GPE | 1 |
il6 il1 tnf | PERSON | 1 |
ip | ORG | 1 |
iv | ORG | 1 |
ipd | ORG | 1 |
ipf zeng et al | ORG | 1 |
ips | ORG | 1 |
iptg | CHEMICAL | 1 |
iran a | ORG | 1 |
irr | ORG | 1 |
immune | LOC | 1 |
immune dysfunction | DISEASE | 1 |
injury prognostic | ORG | 1 |
influenza data | ORG | 1 |
infection prevention and control programs | ORG | 1 |
infections | DISEASE | 1 |
infectious diseases | DISEASE | 1 |
infeção | ORG | 1 |
inflammasome | TAXON | 1 |
influence of resveratrol | PERSON | 1 |
information and communication technologies ict | ORG | 1 |
inducing suppressor | PERSON | 1 |
infraestrutura nacional de computação distribuída incd national infrastructure for distributed computation | ORG | 1 |
ingmar wellach | PERSON | 1 |
ingo lustenberger | PERSON | 1 |
initiative long | PERSON | 1 |
injuries associated with standing electric scooter use craniofacial injuries seen with the introduction of bicycle share electric scooters | ORG | 1 |
injury patterns | ORG | 1 |
infection prevention | ORG | 1 |
inducing cardiomyocyte | PERSON | 1 |
immuno pathogenesis molecular mechanism for antibody dependent enhancement of coronavirus entry | ORG | 1 |
improvement group | ORG | 1 |
immunoglobulin m igm | ORG | 1 |
impact of exercise rehabilitation on exercise capacity and quality of life in heart failure individual participant meta analysis impact | ORG | 1 |
imperial college london | ORG | 1 |
importance of assessing cardiorespiratory fitness | ORG | 1 |
improve health a systematic review low | ORG | 1 |
improved exercise tolerance | PERSON | 1 |
improvement of insulin sensitivity after lean donor feces | ORG | 1 |
indoleamine 2 | ORG | 1 |
inc chicago il usa | ORG | 1 |
inc chicago il usa data | ORG | 1 |
inc dublin | PERSON | 1 |
incubation period and other epidemiological characteristics | ORG | 1 |
indiana | GPE | 1 |
indiana sars cov | ORG | 1 |
milano varese | PERSON | 1 |
obstetric | GPE | 1 |
mild to moderate ulcerative colitis pharmacogenomics | ORG | 1 |
pasqualato sebastiano mapelli marina | PERSON | 1 |
psychiatric | DISEASE | 1 |
psychological | ORG | 1 |
psychological impact on patients with rare | ORG | 1 |
psychometric validation | PERSON | 1 |
pulmocide | CHEMICAL | 1 |
pulmocide ltd | ORG | 1 |
pulmonary group 2 | ORG | 1 |
pulmonary rehabilitation time | PERSON | 1 |
pulmonary vascular endothelialitis thrombosis | DISEASE | 1 |
qc canada | ORG | 1 |
qsr international pty ltd code | ORG | 1 |
qt concentration effect modelling of the sirt1 inhibitor selisistat | ORG | 1 |
qin | PERSON | 1 |
qualitative methods for health research | ORG | 1 |
quantitative optical coherence tomography angiography of radial peripapillary capillaries | ORG | 1 |
psoriasis | DISEASE | 1 |
pseudoherpetic grover disease | DISEASE | 1 |
pseudoherpetic grover disease | DISEASE | 1 |
prolonged qt interval | ORG | 1 |
prevalencia bayesiana | PERSON | 1 |
prevotella | CHEMICAL | 1 |
primary hyperparathyroidism parathyroid carcinoma | DISEASE | 1 |
primary sclerosing cholangitis | DISEASE | 1 |
primary mitochondrial diseases | DISEASE | 1 |
pro | PERSON | 1 |
prone | ORG | 1 |
pseudoherpetic grover | LOC | 1 |
protecting healthcare workers | ORG | 1 |
protection | GPE | 1 |
protein | GPE | 1 |
protein data bank | ORG | 1 |
protezione | CHEMICAL | 1 |
prunet | CHEMICAL | 1 |
queen mary university | ORG | 1 |
querschnittserhebung | PERSON | 1 |
quervain syndrome | DISEASE | 1 |
rv infection | DISEASE | 1 |
rsv bronchiolitis | DISEASE | 1 |
rsv infected bronchitis azithromycin | DISEASE | 1 |
rsv infections | DISEASE | 1 |
rt | ORG | 1 |
rt pcr efficacy | ORG | 1 |
rt pcr virus | ORG | 1 |
ra | CHEMICAL | 1 |
rsv | ORG | 1 |
racial disparities | ORG | 1 |
racial and ethnic disparities in employment outcomes for persons with traumatic brain injury a longitudinal investigation | ORG | 1 |
rakocy kamil raciborski filip | CHEMICAL | 1 |
ram miller | PERSON | 1 |
ramon de la | PERSON | 1 |
ranucci | PERSON | 1 |
rsv infection | DISEASE | 1 |
rquad | ORG | 1 |
r foundation for statistical computing | ORG | 1 |
rham | ORG | 1 |
raasa | ORG | 1 |
rbd iga | DISEASE | 1 |
rbd spike | PERSON | 1 |
recovery | ORG | 1 |
renave | ORG | 1 |
rgfp966 | ORG | 1 |
rna rt pcr | ORG | 1 |
rpe | ORG | 1 |
roi | ORG | 1 |
rom | ORG | 1 |
ros disorders | ORG | 1 |
ros generating mitochondrial dna mutations can regulate tumor cell metastasis mitochondrial | ORG | 1 |
rpcp pd patients | ORG | 1 |
rpcp circulation rpcp pd | ORG | 1 |
prevalence of current and past sars cov 2 infections among police employees | ORG | 1 |
prevalence of comorbidities and its effects | ORG | 1 |
prevalence of antibodies | ORG | 1 |
philyra inc | ORG | 1 |
pfizer inc glaxosmithkline plc | ORG | 1 |
pfizer inc global health alliance | ORG | 1 |
pharma bruxelles belgium | ORG | 1 |
philipp klug alexander nau | PERSON | 1 |
philips medical systems ie33 | ORG | 1 |
philyra | CHEMICAL | 1 |
physiotherapy | PERSON | 1 |
peña fernández | CHEMICAL | 1 |
piccione | CHEMICAL | 1 |
pierre | DISEASE | 1 |
pierre benov avi | PERSON | 1 |
pietropolli adalgisa | PERSON | 1 |
pilar lópez cuervo joaquín fernandez gil sánchez ricardo rabadán | PERSON | 1 |
pillcam tm colon 1 | ORG | 1 |
peña josé | CHEMICAL | 1 |
peter j sagara hironori title | PERSON | 1 |
pityrosporum | PERSON | 1 |
pearson s linear | ORG | 1 |
pathogenesis | DISEASE | 1 |
patients with proliferative diabetic retinopathy | ORG | 1 |
paula aguilera | PERSON | 1 |
pavia genova | PERSON | 1 |
pavone | CHEMICAL | 1 |
pearson | PERSON | 1 |
pediatric clinic department of clinical and experimental medicine | ORG | 1 |
perspective on provided health services | ORG | 1 |
peptone primatone | CHEMICAL | 1 |
peptone primatone rl merck | ORG | 1 |
percivalle | PERSON | 1 |
perniosis | DISEASE | 1 |
perreti et al | GPE | 1 |
persistence | PERSON | 1 |
pirovano | PERSON | 1 |
placenta | ORG | 1 |
pregnancy related liver disorders | DISEASE | 1 |
praevia placenta | PERSON | 1 |
positive | ORG | 1 |
post | ORG | 1 |
posttraumatic | DISEASE | 1 |
posttraumatic stress disorder | DISEASE | 1 |
potential | ORG | 1 |
praevia accreta | PERSON | 1 |
prague | GPE | 1 |
portugal logistic | ORG | 1 |
preconceptional | PERSON | 1 |
preconceptional and maternal obesity | DISEASE | 1 |
prediction of the epidemic peak of coronavirus disease | ORG | 1 |
predominant cxr | PERSON | 1 |
pregnancy outcoms clinical | ORG | 1 |
pregnancy related complications in women with recurrent pregnancy loss a prospective cohort study | ORG | 1 |
portugal risk | ORG | 1 |
portero de la cruz | PERSON | 1 |
plasma membrane | PERSON | 1 |
policlinico tor vergata university hospital | ORG | 1 |
plasmodium vivax | TAXON | 1 |